Motif 675 (n=126)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
O00299 | CLIC1 | S221 | ochoa | Chloride intracellular channel protein 1 (Chloride channel ABP) (Glutaredoxin-like oxidoreductase CLIC1) (EC 1.8.-.-) (Glutathione-dependent dehydroascorbate reductase CLIC1) (EC 1.8.5.1) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC) | In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor. Reduces selenite and dehydroascorbate and may act as an antioxidant during oxidative stress response (PubMed:25581026, PubMed:37759794). Can insert into membranes and form voltage-dependent multi-ion conductive channels. Membrane insertion seems to be redox-regulated and may occur only under oxidizing conditions. Involved in regulation of the cell cycle. {ECO:0000269|PubMed:10834939, ECO:0000269|PubMed:10874038, ECO:0000269|PubMed:11195932, ECO:0000269|PubMed:11551966, ECO:0000269|PubMed:11940526, ECO:0000269|PubMed:11978800, ECO:0000269|PubMed:14613939, ECO:0000269|PubMed:16339885, ECO:0000269|PubMed:25581026, ECO:0000269|PubMed:37759794, ECO:0000269|PubMed:9139710}. |
O14686 | KMT2D | S1722 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O75396 | SEC22B | S174 | ochoa | Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1) | SNARE involved in targeting and fusion of ER-derived transport vesicles with the Golgi complex as well as Golgi-derived retrograde transport vesicles with the ER. {ECO:0000269|PubMed:15272311}. |
O75496 | GMNN | S34 | ochoa | Geminin | Inhibits DNA replication by preventing the incorporation of MCM complex into pre-replication complex (pre-RC) (PubMed:14993212, PubMed:20129055, PubMed:24064211, PubMed:9635433). It is degraded during the mitotic phase of the cell cycle (PubMed:14993212, PubMed:24064211, PubMed:9635433). Its destruction at the metaphase-anaphase transition permits replication in the succeeding cell cycle (PubMed:14993212, PubMed:24064211, PubMed:9635433). Inhibits histone acetyltransferase activity of KAT7/HBO1 in a CDT1-dependent manner, inhibiting histone H4 acetylation and DNA replication licensing (PubMed:20129055). Inhibits the transcriptional activity of a subset of Hox proteins, enrolling them in cell proliferative control (PubMed:22615398). {ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:20129055, ECO:0000269|PubMed:22615398, ECO:0000269|PubMed:24064211, ECO:0000269|PubMed:9635433}. |
O94804 | STK10 | S514 | ochoa | Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) | Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo. {ECO:0000269|PubMed:11903060, ECO:0000269|PubMed:12639966, ECO:0000269|PubMed:19255442}. |
O94916 | NFAT5 | S238 | ochoa | Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP) | Transcription factor involved, among others, in the transcriptional regulation of osmoprotective and inflammatory genes. Binds the DNA consensus sequence 5'-[ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' (PubMed:10377394). Mediates the transcriptional response to hypertonicity (PubMed:10051678). Positively regulates the transcription of LCN2 and S100A4 genes; optimal transactivation of these genes requires the presence of DDX5/DDX17 (PubMed:22266867). Also involved in the DNA damage response by preventing formation of R-loops; R-loops are composed of a DNA:RNA hybrid and the associated non-template single-stranded DNA (PubMed:34049076). {ECO:0000269|PubMed:10051678, ECO:0000269|PubMed:10377394, ECO:0000269|PubMed:22266867, ECO:0000269|PubMed:34049076}. |
P02545 | LMNA | S282 | ochoa | Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] | [Lamin-A/C]: Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:2188730, PubMed:22431096, PubMed:2344612, PubMed:23666920, PubMed:24741066, PubMed:31434876, PubMed:31548606, PubMed:37788673, PubMed:37832547). Lamins provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:22431096, PubMed:23666920, PubMed:24741066, PubMed:31548606, PubMed:37788673, PubMed:37832547). Lamin A and C also regulate matrix stiffness by conferring nuclear mechanical properties (PubMed:23990565, PubMed:25127216). The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively (PubMed:2188730, PubMed:2344612). Lamin A and C are present in equal amounts in the lamina of mammals (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:22431096, PubMed:23666920, PubMed:31548606). Also invoved in DNA repair: recruited by DNA repair proteins XRCC4 and IFFO1 to the DNA double-strand breaks (DSBs) to prevent chromosome translocation by immobilizing broken DNA ends (PubMed:31548606). Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:10814726, PubMed:11799477, PubMed:18551513, PubMed:22431096). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477, ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:2188730, ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:2344612, ECO:0000269|PubMed:23666920, ECO:0000269|PubMed:23990565, ECO:0000269|PubMed:24741066, ECO:0000269|PubMed:25127216, ECO:0000269|PubMed:31434876, ECO:0000269|PubMed:31548606, ECO:0000269|PubMed:37788673, ECO:0000269|PubMed:37832547}.; FUNCTION: [Prelamin-A/C]: Prelamin-A/C can accelerate smooth muscle cell senescence (PubMed:20458013). It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence (PubMed:20458013). {ECO:0000269|PubMed:20458013}. |
P06753 | TPM3 | S62 | ochoa | Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5) | Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. {ECO:0000250|UniProtKB:P09493}. |
P06753 | TPM3 | S216 | ochoa | Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5) | Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. {ECO:0000250|UniProtKB:P09493}. |
P07197 | NEFM | S783 | ochoa | Neurofilament medium polypeptide (NF-M) (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein) | Neurofilaments usually contain three intermediate filament proteins: NEFL, NEFM, and NEFH which are involved in the maintenance of neuronal caliber. May additionally cooperate with the neuronal intermediate filament proteins PRPH and INA to form neuronal filamentous networks (By similarity). {ECO:0000250|UniProtKB:P08553}. |
P07919 | UQCRH | S58 | ochoa | Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein) | Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c. {ECO:0000269|PubMed:34750991}. |
P07942 | LAMB1 | S1222 | ochoa | Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) | Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Involved in the organization of the laminar architecture of cerebral cortex. It is probably required for the integrity of the basement membrane/glia limitans that serves as an anchor point for the endfeet of radial glial cells and as a physical barrier to migrating neurons. Radial glial cells play a central role in cerebral cortical development, where they act both as the proliferative unit of the cerebral cortex and a scaffold for neurons migrating toward the pial surface. {ECO:0000269|PubMed:23472759}. |
P07951 | TPM2 | S61 | ochoa | Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2) | Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. The non-muscle isoform may have a role in agonist-mediated receptor internalization. {ECO:0000250|UniProtKB:P58774, ECO:0000250|UniProtKB:P58775}. |
P07951 | TPM2 | S215 | ochoa | Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2) | Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. The non-muscle isoform may have a role in agonist-mediated receptor internalization. {ECO:0000250|UniProtKB:P58774, ECO:0000250|UniProtKB:P58775}. |
P09493 | TPM1 | S61 | psp | Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1) | Binds to actin filaments in muscle and non-muscle cells (PubMed:23170982). Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction (PubMed:23170982). Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. |
P09960 | LTA4H | S81 | ochoa | Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4) | Bifunctional zinc metalloenzyme that comprises both epoxide hydrolase (EH) and aminopeptidase activities. Acts as an epoxide hydrolase to catalyze the conversion of LTA4 to the pro-inflammatory mediator leukotriene B4 (LTB4) (PubMed:11917124, PubMed:12207002, PubMed:15078870, PubMed:18804029, PubMed:1897988, PubMed:1975494, PubMed:2244921). Also has aminopeptidase activity, with high affinity for N-terminal arginines of various synthetic tripeptides (PubMed:18804029, PubMed:20813919). In addition to its pro-inflammatory EH activity, may also counteract inflammation by its aminopeptidase activity, which inactivates by cleavage another neutrophil attractant, the tripeptide Pro-Gly-Pro (PGP), a bioactive fragment of collagen generated by the action of matrix metalloproteinase-9 (MMP9) and prolylendopeptidase (PREPL) (PubMed:20813919, PubMed:24591641). Involved also in the biosynthesis of resolvin E1 and 18S-resolvin E1 from eicosapentaenoic acid, two lipid mediators that show potent anti-inflammatory and pro-resolving actions (PubMed:21206090). {ECO:0000269|PubMed:11917124, ECO:0000269|PubMed:12207002, ECO:0000269|PubMed:15078870, ECO:0000269|PubMed:18804029, ECO:0000269|PubMed:1897988, ECO:0000269|PubMed:1975494, ECO:0000269|PubMed:20813919, ECO:0000269|PubMed:21206090, ECO:0000269|PubMed:2244921, ECO:0000269|PubMed:24591641}. |
P17677 | GAP43 | S130 | ochoa | Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46) | This protein is associated with nerve growth. It is a major component of the motile 'growth cones' that form the tips of elongating axons. Plays a role in axonal and dendritic filopodia induction. {ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:21152083}. |
P18583 | SON | S154 | ochoa | Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3) | RNA-binding protein that acts as a mRNA splicing cofactor by promoting efficient splicing of transcripts that possess weak splice sites. Specifically promotes splicing of many cell-cycle and DNA-repair transcripts that possess weak splice sites, such as TUBG1, KATNB1, TUBGCP2, AURKB, PCNT, AKT1, RAD23A, and FANCG. Probably acts by facilitating the interaction between Serine/arginine-rich proteins such as SRSF2 and the RNA polymerase II. Also binds to DNA; binds to the consensus DNA sequence: 5'-GA[GT]AN[CG][AG]CC-3'. May indirectly repress hepatitis B virus (HBV) core promoter activity and transcription of HBV genes and production of HBV virions. Essential for correct RNA splicing of multiple genes critical for brain development, neuronal migration and metabolism, including TUBG1, FLNA, PNKP, WDR62, PSMD3, PCK2, PFKL, IDH2, and ACY1 (PubMed:27545680). {ECO:0000269|PubMed:20581448, ECO:0000269|PubMed:21504830, ECO:0000269|PubMed:27545680}. |
P25205 | MCM3 | S734 | ochoa | DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). Required for the entry in S phase and for cell division (Probable). {ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000305|PubMed:35585232}. |
P27348 | YWHAQ | S92 | ochoa | 14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1) | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1. {ECO:0000269|PubMed:12177059}. |
P30101 | PDIA3 | S163 | ochoa | Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60) | Protein disulfide isomerase that catalyzes the formation, isomerization, and reduction or oxidation of disulfide bonds in client proteins and functions as a protein folding chaperone (PubMed:11825568, PubMed:16193070, PubMed:27897272, PubMed:36104323, PubMed:7487104). Core component of the major histocompatibility complex class I (MHC I) peptide loading complex where it functions as an essential folding chaperone for TAPBP. Through TAPBP, assists the dynamic assembly of the MHC I complex with high affinity antigens in the endoplasmic reticulum. Therefore, plays a crucial role in the presentation of antigens to cytotoxic T cells in adaptive immunity (PubMed:35948544, PubMed:36104323). {ECO:0000269|PubMed:11825568, ECO:0000269|PubMed:16193070, ECO:0000269|PubMed:27897272, ECO:0000269|PubMed:35948544, ECO:0000269|PubMed:36104323, ECO:0000269|PubMed:7487104}. |
P30740 | SERPINB1 | S299 | ochoa | Leukocyte elastase inhibitor (LEI) (Monocyte/neutrophil elastase inhibitor) (EI) (M/NEI) (Peptidase inhibitor 2) (PI-2) (Serpin B1) | Neutrophil serine protease inhibitor that plays an essential role in the regulation of the innate immune response, inflammation and cellular homeostasis (PubMed:30692621). Acts primarily to protect the cell from proteases released in the cytoplasm during stress or infection. These proteases are important in killing microbes but when released from granules, these potent enzymes also destroy host proteins and contribute to mortality. Regulates the activity of the neutrophil proteases elastase, cathepsin G, proteinase-3, chymase, chymotrypsin, and kallikrein-3 (PubMed:11747453, PubMed:30692621). Also acts as a potent intracellular inhibitor of GZMH by directly blocking its proteolytic activity (PubMed:23269243). During inflammation, limits the activity of inflammatory caspases CASP1, CASP4 and CASP5 by suppressing their caspase-recruitment domain (CARD) oligomerization and enzymatic activation (PubMed:30692621). When secreted, promotes the proliferation of beta-cells via its protease inhibitory function (PubMed:26701651). {ECO:0000269|PubMed:11747453, ECO:0000269|PubMed:23269243, ECO:0000269|PubMed:26701651, ECO:0000269|PubMed:30692621}. |
P31629 | HIVEP2 | S1616 | ochoa | Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2) | This protein specifically binds to the DNA sequence 5'-GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, somatostatin receptor II, and interferon-beta genes. It may act in T-cell activation. |
P35367 | HRH1 | S318 | ochoa | Histamine H1 receptor (H1-R) (H1R) (HH1R) | G-protein-coupled receptor for histamine, a biogenic amine that functions as an immune modulator and a neurotransmitter (PubMed:33828102, PubMed:8280179). Through the H1 receptor, histamine mediates the contraction of smooth muscles and increases capillary permeability due to contraction of terminal venules. Also mediates neurotransmission in the central nervous system and thereby regulates circadian rhythms, emotional and locomotor activities as well as cognitive functions (By similarity). {ECO:0000250|UniProtKB:P70174, ECO:0000269|PubMed:33828102, ECO:0000269|PubMed:8280179}. |
P49902 | NT5C2 | S511 | ochoa | Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic 5'-nucleotidase II) (cN-II) (Cytosolic IMP/GMP-specific 5'-nucleotidase) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77) (High Km 5'-nucleotidase) | Broad specificity cytosolic 5'-nucleotidase that catalyzes the dephosphorylation of 6-hydroxypurine nucleoside 5'-monophosphates (PubMed:10092873, PubMed:12907246, PubMed:1659319, PubMed:9371705). In addition, possesses a phosphotransferase activity by which it can transfer a phosphate from a donor nucleoside monophosphate to an acceptor nucleoside, preferably inosine, deoxyinosine and guanosine (PubMed:1659319, PubMed:9371705). Has the highest activities for IMP and GMP followed by dIMP, dGMP and XMP (PubMed:10092873, PubMed:12907246, PubMed:1659319, PubMed:9371705). Could also catalyze the transfer of phosphates from pyrimidine monophosphates but with lower efficiency (PubMed:1659319, PubMed:9371705). Through these activities regulates the purine nucleoside/nucleotide pools within the cell (PubMed:10092873, PubMed:12907246, PubMed:1659319, PubMed:9371705). {ECO:0000269|PubMed:10092873, ECO:0000269|PubMed:12907246, ECO:0000269|PubMed:1659319, ECO:0000269|PubMed:9371705}. |
P54278 | PMS2 | S403 | ochoa | Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2) | Component of the post-replicative DNA mismatch repair system (MMR) (PubMed:30653781, PubMed:35189042). Heterodimerizes with MLH1 to form MutL alpha. DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH3) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Possesses an ATPase activity, but in the absence of gross structural changes, ATP hydrolysis may not be necessary for proficient mismatch repair (PubMed:35189042). {ECO:0000269|PubMed:16873062, ECO:0000269|PubMed:18206974, ECO:0000269|PubMed:23709753, ECO:0000269|PubMed:30653781, ECO:0000269|PubMed:35189042}. |
P60709 | ACTB | S234 | ochoa | Actin, cytoplasmic 1 (EC 3.6.4.-) (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:25255767, PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:29925947). Plays a role in the assembly of the gamma-tubulin ring complex (gTuRC), which regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments (PubMed:39321809, PubMed:38609661). Part of the ACTR1A/ACTB filament around which the dynactin complex is built (By similarity). The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). {ECO:0000250|UniProtKB:Q6QAQ1, ECO:0000269|PubMed:25255767, ECO:0000269|PubMed:29581253, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
P62495 | ETF1 | S123 | ochoa | Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Protein Cl1) (TB3-1) | Component of the eRF1-eRF3-GTP ternary complex, a ternary complex that mediates translation termination in response to the termination codons (PubMed:10676813, PubMed:16777602, PubMed:24486019, PubMed:26245381, PubMed:27863242, PubMed:36638793, PubMed:7990965). The eRF1-eRF3-GTP complex binds to a stop codon in the ribosomal A-site (PubMed:26245381, PubMed:27863242, PubMed:36638793). ETF1/ERF1 is responsible for stop codon recognition and inducing hydrolysis of peptidyl-tRNA (PubMed:26245381, PubMed:27863242, PubMed:36638793). Following GTP hydrolysis, eRF3 (GSPT1/ERF3A or GSPT2/ERF3B) dissociates, permitting ETF1/eRF1 to accommodate fully in the A-site and mediate hydrolysis of peptidyl-tRNA (PubMed:10676813, PubMed:16777602, PubMed:26245381, PubMed:27863242). Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:19417104). Required for SHFL-mediated translation termination which inhibits programmed ribosomal frameshifting (-1PRF) of mRNA from viruses and cellular genes (PubMed:30682371). {ECO:0000269|PubMed:10676813, ECO:0000269|PubMed:16777602, ECO:0000269|PubMed:19417104, ECO:0000269|PubMed:24486019, ECO:0000269|PubMed:26245381, ECO:0000269|PubMed:27863242, ECO:0000269|PubMed:30682371, ECO:0000269|PubMed:36638793, ECO:0000269|PubMed:7990965}. |
P62736 | ACTA2 | S236 | ochoa | Actin, aortic smooth muscle (EC 3.6.4.-) (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein) [Cleaved into: Actin, aortic smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P63261 | ACTG1 | S234 | ochoa | Actin, cytoplasmic 2 (EC 3.6.4.-) (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity). {ECO:0000250|UniProtKB:P63260, ECO:0000305|PubMed:29581253}. |
P63267 | ACTG2 | S235 | ochoa | Actin, gamma-enteric smooth muscle (EC 3.6.4.-) (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin) [Cleaved into: Actin, gamma-enteric smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P67936 | TPM4 | S179 | ochoa | Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4) | Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments (By similarity). Binds calcium (PubMed:1836432). Plays a role in platelet biogenesis. {ECO:0000250|UniProtKB:P09495, ECO:0000269|PubMed:1836432, ECO:0000269|PubMed:28134622, ECO:0000269|PubMed:35170221}. |
P68032 | ACTC1 | S236 | ochoa | Actin, alpha cardiac muscle 1 (EC 3.6.4.-) (Alpha-cardiac actin) [Cleaved into: Actin, alpha cardiac muscle 1, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68133 | ACTA1 | S236 | ochoa | Actin, alpha skeletal muscle (EC 3.6.4.-) (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P78316 | NOP14 | S239 | ochoa | Nucleolar protein 14 (Nucleolar complex protein 14) | Involved in nucleolar processing of pre-18S ribosomal RNA. Has a role in the nuclear export of 40S pre-ribosomal subunit to the cytoplasm (By similarity). {ECO:0000250}. |
Q01082 | SPTBN1 | S769 | ochoa | Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1) | Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane. Plays a critical role in central nervous system development and function. {ECO:0000269|PubMed:34211179}. |
Q01484 | ANK2 | S2248 | ochoa | Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin) | Plays an essential role in the localization and membrane stabilization of ion transporters and ion channels in several cell types, including cardiomyocytes, as well as in striated muscle cells. In skeletal muscle, required for proper localization of DMD and DCTN4 and for the formation and/or stability of a special subset of microtubules associated with costameres and neuromuscular junctions. In cardiomyocytes, required for coordinate assembly of Na/Ca exchanger, SLC8A1/NCX1, Na/K ATPases ATP1A1 and ATP1A2 and inositol 1,4,5-trisphosphate (InsP3) receptors at sarcoplasmic reticulum/sarcolemma sites. Required for expression and targeting of SPTBN1 in neonatal cardiomyocytes and for the regulation of neonatal cardiomyocyte contraction rate (PubMed:12571597). In the inner segment of rod photoreceptors, required for the coordinated expression of the Na/K ATPase, Na/Ca exchanger and beta-2-spectrin (SPTBN1) (By similarity). Plays a role in endocytosis and intracellular protein transport. Associates with phosphatidylinositol 3-phosphate (PI3P)-positive organelles and binds dynactin to promote long-range motility of cells. Recruits RABGAP1L to (PI3P)-positive early endosomes, where RABGAP1L inactivates RAB22A, and promotes polarized trafficking to the leading edge of the migrating cells. Part of the ANK2/RABGAP1L complex which is required for the polarized recycling of fibronectin receptor ITGA5 ITGB1 to the plasma membrane that enables continuous directional cell migration (By similarity). {ECO:0000250|UniProtKB:Q8C8R3, ECO:0000269|PubMed:12571597}. |
Q01484 | ANK2 | S3910 | ochoa | Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin) | Plays an essential role in the localization and membrane stabilization of ion transporters and ion channels in several cell types, including cardiomyocytes, as well as in striated muscle cells. In skeletal muscle, required for proper localization of DMD and DCTN4 and for the formation and/or stability of a special subset of microtubules associated with costameres and neuromuscular junctions. In cardiomyocytes, required for coordinate assembly of Na/Ca exchanger, SLC8A1/NCX1, Na/K ATPases ATP1A1 and ATP1A2 and inositol 1,4,5-trisphosphate (InsP3) receptors at sarcoplasmic reticulum/sarcolemma sites. Required for expression and targeting of SPTBN1 in neonatal cardiomyocytes and for the regulation of neonatal cardiomyocyte contraction rate (PubMed:12571597). In the inner segment of rod photoreceptors, required for the coordinated expression of the Na/K ATPase, Na/Ca exchanger and beta-2-spectrin (SPTBN1) (By similarity). Plays a role in endocytosis and intracellular protein transport. Associates with phosphatidylinositol 3-phosphate (PI3P)-positive organelles and binds dynactin to promote long-range motility of cells. Recruits RABGAP1L to (PI3P)-positive early endosomes, where RABGAP1L inactivates RAB22A, and promotes polarized trafficking to the leading edge of the migrating cells. Part of the ANK2/RABGAP1L complex which is required for the polarized recycling of fibronectin receptor ITGA5 ITGB1 to the plasma membrane that enables continuous directional cell migration (By similarity). {ECO:0000250|UniProtKB:Q8C8R3, ECO:0000269|PubMed:12571597}. |
Q02880 | TOP2B | S1413 | ochoa | DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme) | Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand. Plays a role in B-cell differentiation. {ECO:0000269|PubMed:10684600, ECO:0000269|PubMed:31409799, ECO:0000269|PubMed:32128574}. |
Q02952 | AKAP12 | S1251 | ochoa | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC). |
Q03164 | KMT2A | S1058 | ochoa | Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] | Histone methyltransferase that plays an essential role in early development and hematopoiesis (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:26886794). Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac) (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:24235145, PubMed:26886794). Catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:25561738, PubMed:26886794). Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity (PubMed:19187761, PubMed:26886794). Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9' (PubMed:19187761). Binds to unmethylated CpG elements in the promoter of target genes and helps maintain them in the nonmethylated state (PubMed:20010842). Required for transcriptional activation of HOXA9 (PubMed:12453419, PubMed:20010842, PubMed:20677832). Promotes PPP1R15A-induced apoptosis (PubMed:10490642). Plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the CLOCK-BMAL1 heterodimer (By similarity). Establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'Lys-4' of histone H3 (H3K4me) and this histone modification directs the circadian acetylation at H3K9 and H3K14 allowing the recruitment of CLOCK-BMAL1 to chromatin (By similarity). Also has auto-methylation activity on Cys-3882 in absence of histone H3 substrate (PubMed:24235145). {ECO:0000250|UniProtKB:P55200, ECO:0000269|PubMed:10490642, ECO:0000269|PubMed:12453419, ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:19187761, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:20010842, ECO:0000269|PubMed:21220120, ECO:0000269|PubMed:24235145, ECO:0000269|PubMed:26886794, ECO:0000305|PubMed:20677832}. |
Q13315 | ATM | S1270 | psp | Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated) | Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor (PubMed:10550055, PubMed:10839545, PubMed:10910365, PubMed:12556884, PubMed:14871926, PubMed:15064416, PubMed:15448695, PubMed:15456891, PubMed:15790808, PubMed:15916964, PubMed:17923702, PubMed:21757780, PubMed:24534091, PubMed:35076389, PubMed:9733514). Recognizes the substrate consensus sequence [ST]-Q (PubMed:10550055, PubMed:10839545, PubMed:10910365, PubMed:12556884, PubMed:14871926, PubMed:15448695, PubMed:15456891, PubMed:15916964, PubMed:17923702, PubMed:24534091, PubMed:9733514). Phosphorylates 'Ser-139' of histone variant H2AX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism (By similarity). Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FBXW7, FANCD2, NFKBIA, BRCA1, CREBBP/CBP, RBBP8/CTIP, FBXO46, MRE11, nibrin (NBN), RAD50, RAD17, PELI1, TERF1, UFL1, RAD9, UBQLN4 and DCLRE1C (PubMed:10550055, PubMed:10766245, PubMed:10802669, PubMed:10839545, PubMed:10910365, PubMed:10973490, PubMed:11375976, PubMed:12086603, PubMed:15456891, PubMed:19965871, PubMed:21757780, PubMed:24534091, PubMed:26240375, PubMed:26774286, PubMed:30171069, PubMed:30612738, PubMed:30886146, PubMed:30952868, PubMed:38128537, PubMed:9733515, PubMed:9843217). May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation (PubMed:19965871). Phosphorylates ATF2 which stimulates its function in DNA damage response (PubMed:15916964). Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (PubMed:29203878). Phosphorylates TTC5/STRAP at 'Ser-203' in the cytoplasm in response to DNA damage, which promotes TTC5/STRAP nuclear localization (PubMed:15448695). Also involved in pexophagy by mediating phosphorylation of PEX5: translocated to peroxisomes in response to reactive oxygen species (ROS), and catalyzes phosphorylation of PEX5, promoting PEX5 ubiquitination and induction of pexophagy (PubMed:26344566). {ECO:0000250|UniProtKB:Q62388, ECO:0000269|PubMed:10550055, ECO:0000269|PubMed:10766245, ECO:0000269|PubMed:10802669, ECO:0000269|PubMed:10839545, ECO:0000269|PubMed:10910365, ECO:0000269|PubMed:10973490, ECO:0000269|PubMed:11375976, ECO:0000269|PubMed:12086603, ECO:0000269|PubMed:12556884, ECO:0000269|PubMed:14871926, ECO:0000269|PubMed:15448695, ECO:0000269|PubMed:15456891, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:16086026, ECO:0000269|PubMed:16858402, ECO:0000269|PubMed:17923702, ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:19965871, ECO:0000269|PubMed:21757780, ECO:0000269|PubMed:24534091, ECO:0000269|PubMed:26240375, ECO:0000269|PubMed:26344566, ECO:0000269|PubMed:26774286, ECO:0000269|PubMed:29203878, ECO:0000269|PubMed:30171069, ECO:0000269|PubMed:30612738, ECO:0000269|PubMed:30886146, ECO:0000269|PubMed:30952868, ECO:0000269|PubMed:35076389, ECO:0000269|PubMed:38128537, ECO:0000269|PubMed:9733514, ECO:0000269|PubMed:9733515, ECO:0000269|PubMed:9843217}. |
Q13416 | ORC2 | S219 | ochoa | Origin recognition complex subunit 2 | Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K20me3 and H4K27me3. Stabilizes LRWD1, by protecting it from ubiquitin-mediated proteasomal degradation. Also stabilizes ORC3. {ECO:0000269|PubMed:22427655, ECO:0000269|PubMed:22935713}. |
Q13442 | PDAP1 | S57 | ochoa | 28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1) | Enhances PDGFA-stimulated cell growth in fibroblasts, but inhibits the mitogenic effect of PDGFB. {ECO:0000250}. |
Q13523 | PRP4K | S285 | ochoa | Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog) | Serine/threonine kinase involved in spliceosomal assembly as well as mitosis and signaling regulation (PubMed:10799319, PubMed:12077342, PubMed:17513757, PubMed:17998396). Connects chromatin mediated regulation of transcription and pre-mRNA splicing (PubMed:12077342). During spliceosomal assembly, interacts with and phosphorylates PRPF6 and PRPF31, components of the U4/U6-U5 tri-small nuclear ribonucleoprotein (snRNP), to facilitate the formation of the spliceosome B complex. Plays a role in regulating transcription and the spindle assembly checkpoint (SAC) (PubMed:20118938). Associates with U5 snRNP and NCOR1 deacetylase complexes which may allow a coordination of pre-mRNA splicing with chromatin remodeling events involved in transcriptional regulation (PubMed:12077342). Associates and probably phosphorylates SMARCA4 and NCOR1 (PubMed:12077342). Phosphorylates SRSF1 (PubMed:11418604). Associates with kinetochores during mitosis and is necessary for recruitment and maintenance of the checkpoint proteins such as MAD1L1 and MAD12L1 at the kinetochores (PubMed:17998396). Phosphorylates and regulates the activity of the transcription factors such as ELK1 and KLF13 (PubMed:10799319, PubMed:17513757). Phosphorylates nuclear YAP1 and WWTR1/TAZ which induces nuclear exclusion and regulates Hippo signaling pathway, involved in tissue growth control (PubMed:29695716). {ECO:0000269|PubMed:10799319, ECO:0000269|PubMed:11418604, ECO:0000269|PubMed:12077342, ECO:0000269|PubMed:17513757, ECO:0000269|PubMed:17998396, ECO:0000269|PubMed:20118938, ECO:0000269|PubMed:29695716}. |
Q14126 | DSG2 | S553 | ochoa | Desmoglein-2 (Cadherin family member 5) (HDGC) | A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:38395410). Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion. Required for proliferation and viability of embryonic stem cells in the blastocyst, thereby crucial for progression of post-implantation embryonic development (By similarity). Maintains pluripotency by regulating epithelial to mesenchymal transition/mesenchymal to epithelial transition (EMT/MET) via interacting with and sequestering CTNNB1 to sites of cell-cell contact, thereby reducing translocation of CTNNB1 to the nucleus and subsequent transcription of CTNNB1/TCF-target genes (PubMed:29910125). Promotes pluripotency and the multi-lineage differentiation potential of hematopoietic stem cells (PubMed:27338829). Plays a role in endothelial cell sprouting and elongation via mediating the junctional-association of cortical actin fibers and CDH5 (PubMed:27338829). Plays a role in limiting inflammatory infiltration and the apoptotic response to injury in kidney tubular epithelial cells, potentially via its role in maintaining cell-cell adhesion and the epithelial barrier (PubMed:38395410). {ECO:0000250|UniProtKB:O55111, ECO:0000269|PubMed:27338829, ECO:0000269|PubMed:29910125, ECO:0000269|PubMed:38395410}. |
Q14676 | MDC1 | S402 | ochoa|psp | Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) | Histone reader protein required for checkpoint-mediated cell cycle arrest in response to DNA damage within both the S phase and G2/M phases of the cell cycle (PubMed:12475977, PubMed:12499369, PubMed:12551934, PubMed:12607003, PubMed:12607004, PubMed:12607005, PubMed:12611903, PubMed:14695167, PubMed:15201865, PubMed:15377652, PubMed:16049003, PubMed:16377563, PubMed:30898438). Specifically recognizes and binds histone H2AX phosphorylated at 'Ser-139', a marker of DNA damage, serving as a scaffold for the recruitment of DNA repair and signal transduction proteins to discrete foci of DNA damage sites (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:30898438). Also required for downstream events subsequent to the recruitment of these proteins (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:18582474). These include phosphorylation and activation of the ATM, CHEK1 and CHEK2 kinases, and stabilization of TP53/p53 and apoptosis (PubMed:12499369, PubMed:12551934, PubMed:12607004). ATM and CHEK2 may also be activated independently by a parallel pathway mediated by TP53BP1 (PubMed:12499369, PubMed:12551934, PubMed:12607004). Required for chromosomal stability during mitosis by promoting recruitment of TOPBP1 to DNA double strand breaks (DSBs): TOPBP1 forms filamentous assemblies that bridge MDC1 and tether broken chromosomes during mitosis (PubMed:30898438). Required for the repair of DSBs via homologous recombination by promoting recruitment of NBN component of the MRN complex to DSBs (PubMed:18411307, PubMed:18582474, PubMed:18583988, PubMed:18678890). {ECO:0000269|PubMed:12475977, ECO:0000269|PubMed:12499369, ECO:0000269|PubMed:12551934, ECO:0000269|PubMed:12607003, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:12611903, ECO:0000269|PubMed:14695167, ECO:0000269|PubMed:15201865, ECO:0000269|PubMed:15377652, ECO:0000269|PubMed:16049003, ECO:0000269|PubMed:16377563, ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18582474, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:30898438}. |
Q14839 | CHD4 | S1245 | ochoa | Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.-) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) | ATP-dependent chromatin-remodeling factor that binds and distorts nucleosomal DNA (PubMed:28977666, PubMed:32543371). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:17626165, PubMed:28977666, PubMed:9804427). Localizes to acetylated damaged chromatin in a ZMYND8-dependent manner, to promote transcriptional repression and double-strand break repair by homologous recombination (PubMed:25593309). Involved in neurogenesis (By similarity). {ECO:0000250|UniProtKB:Q6PDQ2, ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:17626165, ECO:0000269|PubMed:25593309, ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:32543371, ECO:0000269|PubMed:9804427}. |
Q15003 | NCAPH | S408 | ochoa | Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog) | Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases (PubMed:11136719). Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (PubMed:27737959). {ECO:0000269|PubMed:11136719, ECO:0000269|PubMed:27737959}. |
Q15293 | RCN1 | S158 | ochoa | Reticulocalbin-1 | May regulate calcium-dependent activities in the endoplasmic reticulum lumen or post-ER compartment. |
Q15643 | TRIP11 | S755 | ochoa | Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230) | Is a membrane tether required for vesicle tethering to Golgi. Has an essential role in the maintenance of Golgi structure and function (PubMed:25473115, PubMed:30728324). It is required for efficient anterograde and retrograde trafficking in the early secretory pathway, functioning at both the ER-to-Golgi intermediate compartment (ERGIC) and Golgi complex (PubMed:25717001). Binds the ligand binding domain of the thyroid receptor (THRB) in the presence of triiodothyronine and enhances THRB-modulated transcription. {ECO:0000269|PubMed:10189370, ECO:0000269|PubMed:25473115, ECO:0000269|PubMed:25717001, ECO:0000269|PubMed:30728324, ECO:0000269|PubMed:9256431}. |
Q16513 | PKN2 | S167 | ochoa | Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) | PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}. |
Q16625 | OCLN | S490 | psp | Occludin | May play a role in the formation and regulation of the tight junction (TJ) paracellular permeability barrier. It is able to induce adhesion when expressed in cells lacking tight junctions. {ECO:0000269|PubMed:19114660}.; FUNCTION: (Microbial infection) Acts as a coreceptor for hepatitis C virus (HCV) in hepatocytes. {ECO:0000269|PubMed:19182773, ECO:0000269|PubMed:20375010}. |
Q4KMP7 | TBC1D10B | S288 | ochoa | TBC1 domain family member 10B (Rab27A-GAP-beta) | Acts as a GTPase-activating protein for RAB3A, RAB22A, RAB27A, and RAB35. Does not act on RAB2A and RAB6A. {ECO:0000269|PubMed:16923811, ECO:0000269|PubMed:19077034}. |
Q4LE39 | ARID4B | S772 | ochoa | AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1) | Acts as a transcriptional repressor (PubMed:12724404). May function in the assembly and/or enzymatic activity of the Sin3A corepressor complex or in mediating interactions between the complex and other regulatory complexes (PubMed:12724404). Plays a role in the regulation of epigenetic modifications at the PWS/AS imprinting center near the SNRPN promoter, where it might function as part of a complex with RB1 and ARID4A. Involved in spermatogenesis, together with ARID4A, where it functions as a transcriptional coactivator for AR (androgen receptor) and enhances expression of genes required for sperm maturation. Regulates expression of the tight junction protein CLDN3 in the testis, which is important for integrity of the blood-testis barrier. Plays a role in myeloid homeostasis where it regulates the histone methylation state of bone marrow cells and expression of various genes involved in hematopoiesis. May function as a leukemia suppressor (By similarity). {ECO:0000250|UniProtKB:A2CG63, ECO:0000269|PubMed:12724404}. |
Q53EZ4 | CEP55 | S162 | ochoa | Centrosomal protein of 55 kDa (Cep55) (Up-regulated in colon cancer 6) | Plays a role in mitotic exit and cytokinesis (PubMed:16198290, PubMed:17853893). Recruits PDCD6IP and TSG101 to midbody during cytokinesis. Required for successful completion of cytokinesis (PubMed:17853893). Not required for microtubule nucleation (PubMed:16198290). Plays a role in the development of the brain and kidney (PubMed:28264986). {ECO:0000269|PubMed:16198290, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:28264986}. |
Q562R1 | ACTBL2 | S235 | ochoa | Beta-actin-like protein 2 (Kappa-actin) | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. {ECO:0000250}. |
Q5JTJ3 | COA6 | S84 | ochoa | Cytochrome c oxidase assembly factor 6 homolog | Involved in the maturation of the mitochondrial respiratory chain complex IV subunit MT-CO2/COX2. Thereby, may regulate early steps of complex IV assembly. Mitochondrial respiratory chain complex IV or cytochrome c oxidase is the component of the respiratory chain that catalyzes the transfer of electrons from intermembrane space cytochrome c to molecular oxygen in the matrix and as a consequence contributes to the proton gradient involved in mitochondrial ATP synthesis. May also be required for efficient formation of respiratory supercomplexes comprised of complexes III and IV. {ECO:0000269|PubMed:24549041, ECO:0000269|PubMed:25959673, ECO:0000269|PubMed:26160915}. |
Q5T5P2 | KIAA1217 | S1628 | ochoa | Sickle tail protein homolog | Required for normal development of intervertebral disks. {ECO:0000250|UniProtKB:A2AQ25}. |
Q5T7W0 | ZNF618 | S429 | ochoa | Zinc finger protein 618 | Regulates UHRF2 function as a specific 5-hydroxymethylcytosine (5hmC) reader by regulating its chromatin localization. {ECO:0000269|PubMed:27129234}. |
Q5T9S5 | CCDC18 | S719 | ochoa | Coiled-coil domain-containing protein 18 (Sarcoma antigen NY-SAR-24) | None |
Q5UIP0 | RIF1 | S1394 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5UIP0 | RIF1 | S1613 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q6S8J3 | POTEE | S934 | ochoa | POTE ankyrin domain family member E (ANKRD26-like family C member 1A) (Prostate, ovary, testis-expressed protein on chromosome 2) (POTE-2) | None |
Q6UB98 | ANKRD12 | S1144 | ochoa | Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein) | May recruit HDACs to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation. |
Q6ZNB6 | NFXL1 | S107 | ochoa | NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein) (hOZFP) | None |
Q7L7V1 | DHX32 | S561 | ochoa | Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 (EC 3.6.4.13) (DEAD/H box 32) (DEAD/H helicase-like protein 1) (DHLP1) (DEAH box protein 32) (HuDDX32) | None |
Q86U86 | PBRM1 | S605 | ochoa | Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. {ECO:0000269|PubMed:21248752, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
Q86UP2 | KTN1 | S1180 | ochoa | Kinectin (CG-1 antigen) (Kinesin receptor) | Receptor for kinesin thus involved in kinesin-driven vesicle motility. Accumulates in integrin-based adhesion complexes (IAC) upon integrin aggregation by fibronectin. |
Q86V21 | AACS | S84 | ochoa | Acetoacetyl-CoA synthetase (EC 6.2.1.16) (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog) | Converts acetoacetate to acetoacetyl-CoA in the cytosol (By similarity). Ketone body-utilizing enzyme, responsible for the synthesis of cholesterol and fatty acids (By similarity). {ECO:0000250|UniProtKB:Q9D2R0, ECO:0000250|UniProtKB:Q9JMI1}. |
Q86VH2 | KIF27 | S911 | ochoa | Kinesin-like protein KIF27 | Plays an essential role in motile ciliogenesis. {ECO:0000250}. |
Q8IWT6 | LRRC8A | S199 | ochoa | Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (HsLRRC8A) (Swelling protein 1) | Essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes (PubMed:24725410, PubMed:24790029, PubMed:26530471, PubMed:26824658, PubMed:28193731, PubMed:29769723). The VRAC channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine (PubMed:24725410, PubMed:24790029, PubMed:26530471, PubMed:26824658, PubMed:28193731, PubMed:30095067). Mediates efflux of amino acids, such as aspartate and glutamate, in response to osmotic stress (PubMed:28193731). LRRC8A and LRRC8D are required for the uptake of the drug cisplatin (PubMed:26530471). In complex with LRRC8C or LRRC8E, acts as a transporter of immunoreactive cyclic dinucleotide GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytosol: mediates both import and export of 2'-3'-cGAMP, thereby promoting transfer of 2'-3'-cGAMP to bystander cells (PubMed:33171122). In contrast, complexes containing LRRC8D inhibit transport of 2'-3'-cGAMP (PubMed:33171122). Required for in vivo channel activity, together with at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channel characteristics depend on the precise subunit composition (PubMed:24790029, PubMed:26824658, PubMed:28193731). Can form functional channels by itself (in vitro) (PubMed:26824658). Involved in B-cell development: required for the pro-B cell to pre-B cell transition (PubMed:14660746). Also required for T-cell development (By similarity). Required for myoblast differentiation: VRAC activity promotes membrane hyperpolarization and regulates insulin-stimulated glucose metabolism and oxygen consumption (By similarity). Also acts as a regulator of glucose-sensing in pancreatic beta cells: VRAC currents, generated in response to hypotonicity- or glucose-induced beta cell swelling, depolarize cells, thereby causing electrical excitation, leading to increase glucose sensitivity and insulin secretion (PubMed:29371604). Also plays a role in lysosome homeostasis by forming functional lysosomal VRAC channels in response to low cytoplasmic ionic strength condition: lysosomal VRAC channels are necessary for the formation of large lysosome-derived vacuoles, which store and then expel excess water to maintain cytosolic water homeostasis (PubMed:31270356, PubMed:33139539). Acts as a key factor in NLRP3 inflammasome activation by modulating itaconate efflux and mitochondria function (PubMed:39909992). {ECO:0000250|UniProtKB:Q80WG5, ECO:0000269|PubMed:14660746, ECO:0000269|PubMed:24725410, ECO:0000269|PubMed:24790029, ECO:0000269|PubMed:26530471, ECO:0000269|PubMed:26824658, ECO:0000269|PubMed:28193731, ECO:0000269|PubMed:29371604, ECO:0000269|PubMed:29769723, ECO:0000269|PubMed:30095067, ECO:0000269|PubMed:31270356, ECO:0000269|PubMed:33139539, ECO:0000269|PubMed:33171122, ECO:0000269|PubMed:39909992}. |
Q8IYS0 | GRAMD1C | S224 | ochoa | Protein Aster-C (GRAM domain-containing protein 1C) | Cholesterol transporter that mediates non-vesicular transport of cholesterol from the plasma membrane (PM) to the endoplasmic reticulum (ER) (By similarity). Contains unique domains for binding cholesterol and the PM, thereby serving as a molecular bridge for the transfer of cholesterol from the PM to the ER (By similarity). Plays a crucial role in cholesterol homeostasis and has the unique ability to localize to the PM based on the level of membrane cholesterol (By similarity). In lipid-poor conditions localizes to the ER membrane and in response to excess cholesterol in the PM is recruited to the endoplasmic reticulum-plasma membrane contact sites (EPCS) which is mediated by the GRAM domain (By similarity). At the EPCS, the sterol-binding VASt/ASTER domain binds to the cholesterol in the PM and facilitates its transfer from the PM to ER (By similarity). {ECO:0000250|UniProtKB:Q8CI52}. |
Q8NFG4 | FLCN | S537 | psp | Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein) | Multi-functional protein, involved in both the cellular response to amino acid availability and in the regulation of glycolysis (PubMed:17028174, PubMed:18663353, PubMed:21209915, PubMed:24081491, PubMed:24095279, PubMed:31672913, PubMed:31704029, PubMed:32612235, PubMed:34381247, PubMed:36103527, PubMed:37079666). GTPase-activating protein that plays a key role in the cellular response to amino acid availability through regulation of the non-canonical mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3 (PubMed:17028174, PubMed:18663353, PubMed:21209915, PubMed:24081491, PubMed:24095279, PubMed:24448649, PubMed:31672913, PubMed:31704029, PubMed:32612235, PubMed:36103527, PubMed:37079666). Activates mTORC1 by acting as a GTPase-activating protein: specifically stimulates GTP hydrolysis by RagC/RRAGC or RagD/RRAGD, promoting the conversion to the GDP-bound state of RagC/RRAGC or RagD/RRAGD, and thereby activating the kinase activity of mTORC1 (PubMed:24095279, PubMed:31672913, PubMed:31704029, PubMed:32612235, PubMed:37079666). The GTPase-activating activity is inhibited during starvation and activated in presence of nutrients (PubMed:31672913, PubMed:32612235). Acts as a key component for non-canonical mTORC1-dependent control of the MiT/TFE factors TFEB and TFE3, while it is not involved in mTORC1-dependent phosphorylation of canonical RPS6KB1/S6K1 and EIF4EBP1/4E-BP1 (PubMed:21209915, PubMed:24081491, PubMed:31672913, PubMed:32612235). In low-amino acid conditions, the lysosomal folliculin complex (LFC) is formed on the membrane of lysosomes, which inhibits the GTPase-activating activity of FLCN, inactivates mTORC1 and maximizes nuclear translocation of TFEB and TFE3 (PubMed:31672913). Upon amino acid restimulation, RagA/RRAGA (or RagB/RRAGB) nucleotide exchange promotes disassembly of the LFC complex and liberates the GTPase-activating activity of FLCN, leading to activation of mTORC1 and subsequent cytoplasmic retention of TFEB and TFE3 (PubMed:31672913). Indirectly acts as a positive regulator of Wnt signaling by promoting mTOR-dependent cytoplasmic retention of MiT/TFE factor TFE3 (PubMed:31272105). Required for the exit of hematopoietic stem cell from pluripotency by promoting mTOR-dependent cytoplasmic retention of TFE3, thereby increasing Wnt signaling (PubMed:30733432). Acts as an inhibitor of browning of adipose tissue by regulating mTOR-dependent cytoplasmic retention of TFE3 (By similarity). Involved in the control of embryonic stem cells differentiation; together with LAMTOR1 it is necessary to recruit and activate RagC/RRAGC and RagD/RRAGD at the lysosomes, and to induce exit of embryonic stem cells from pluripotency via non-canonical, mTOR-independent TFE3 inactivation (By similarity). In response to flow stress, regulates STK11/LKB1 accumulation and mTORC1 activation through primary cilia: may act by recruiting STK11/LKB1 to primary cilia for activation of AMPK resided at basal bodies, causing mTORC1 down-regulation (PubMed:27072130). Together with FNIP1 and/or FNIP2, regulates autophagy: following phosphorylation by ULK1, interacts with GABARAP and promotes autophagy (PubMed:25126726). Required for starvation-induced perinuclear clustering of lysosomes by promoting association of RILP with its effector RAB34 (PubMed:27113757). Regulates glycolysis by binding to lactate dehydrogenase LDHA, acting as an uncompetitive inhibitor (PubMed:34381247). {ECO:0000250|UniProtKB:Q8QZS3, ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353, ECO:0000269|PubMed:21209915, ECO:0000269|PubMed:24081491, ECO:0000269|PubMed:24095279, ECO:0000269|PubMed:24448649, ECO:0000269|PubMed:25126726, ECO:0000269|PubMed:27072130, ECO:0000269|PubMed:27113757, ECO:0000269|PubMed:30733432, ECO:0000269|PubMed:31272105, ECO:0000269|PubMed:31672913, ECO:0000269|PubMed:31704029, ECO:0000269|PubMed:32612235, ECO:0000269|PubMed:34381247, ECO:0000269|PubMed:36103527, ECO:0000269|PubMed:37079666}. |
Q8TD26 | CHD6 | S1673 | ochoa | Chromodomain-helicase-DNA-binding protein 6 (CHD-6) (EC 3.6.4.-) (ATP-dependent helicase CHD6) (Radiation-induced gene B protein) | ATP-dependent chromatin-remodeling factor (PubMed:17027977, PubMed:28533432). Regulates transcription by disrupting nucleosomes in a largely non-sliding manner which strongly increases the accessibility of chromatin; nucleosome disruption requires ATP (PubMed:28533432). Activates transcription of specific genes in response to oxidative stress through interaction with NFE2L2. {ECO:0000269|PubMed:16314513, ECO:0000269|PubMed:17027977, ECO:0000269|PubMed:28533432}.; FUNCTION: (Microbial infection) Acts as a transcriptional repressor of different viruses including influenza virus or papillomavirus. During influenza virus infection, the viral polymerase complex localizes CHD6 to inactive chromatin where it gets degraded in a proteasome independent-manner. {ECO:0000269|PubMed:20631145, ECO:0000269|PubMed:21899694, ECO:0000269|PubMed:23408615}. |
Q8TDY2 | RB1CC1 | S1221 | ochoa | RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) | Involved in autophagy (PubMed:21775823). Regulates early events but also late events of autophagosome formation through direct interaction with Atg16L1 (PubMed:23392225). Required for the formation of the autophagosome-like double-membrane structure that surrounds the Salmonella-containing vacuole (SCV) during S.typhimurium infection and subsequent xenophagy (By similarity). Involved in repair of DNA damage caused by ionizing radiation, which subsequently improves cell survival by decreasing apoptosis (By similarity). Inhibits PTK2/FAK1 and PTK2B/PYK2 kinase activity, affecting their downstream signaling pathways (PubMed:10769033, PubMed:12221124). Plays a role as a modulator of TGF-beta-signaling by restricting substrate specificity of RNF111 (By similarity). Functions as a DNA-binding transcription factor (PubMed:12095676). Is a potent regulator of the RB1 pathway through induction of RB1 expression (PubMed:14533007). Plays a crucial role in muscular differentiation (PubMed:12163359). Plays an indispensable role in fetal hematopoiesis and in the regulation of neuronal homeostasis (By similarity). {ECO:0000250|UniProtKB:Q9ESK9, ECO:0000269|PubMed:10769033, ECO:0000269|PubMed:12095676, ECO:0000269|PubMed:12163359, ECO:0000269|PubMed:12221124, ECO:0000269|PubMed:14533007, ECO:0000269|PubMed:21775823, ECO:0000269|PubMed:23392225}. |
Q8WXW3 | PIBF1 | S703 | ochoa | Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90) | Plays a role in ciliogenesis. {ECO:0000269|PubMed:26167768}.; FUNCTION: [Isoform 1]: Pericentriolar protein required to maintain mitotic spindle pole integrity (PubMed:21224392). Required for the centrosomal accumulation of PCM1 and the recruitment of centriolar satellite proteins such as BBS4. Via association with PCM1 may be involved in primary cilia formation (PubMed:23110211). Required for CEP63 centrosomal localization and its interaction with WDR62. Together with CEP63 promotes centriole duplication. Promotes the centrosomal localization of CDK2 (PubMed:26297806). {ECO:0000269|PubMed:21224392, ECO:0000269|PubMed:23110211, ECO:0000269|PubMed:26297806}.; FUNCTION: [Isoform 4]: The secreted form is a mediator of progesterone that by acting on the phospholipase A2 enzyme interferes with arachidonic acid metabolism, induces a Th2 biased immune response, and by controlling decidual natural killer cells (NK) activity exerts an anti-abortive effect (PubMed:12516630, PubMed:14634107, PubMed:3863495). Increases the production of Th2-type cytokines by signaling via the JAK/STAT pathway. Activates STAT6 and inhibits STAT4 phosphorylation. Signaling via a not identified receptor seems to implicate IL4R and a GPI-anchored protein (PubMed:16393965, PubMed:25218441). {ECO:0000269|PubMed:12516630, ECO:0000269|PubMed:14634107, ECO:0000269|PubMed:16393965, ECO:0000269|PubMed:25218441, ECO:0000269|PubMed:3863495, ECO:0000305|PubMed:11407300}. |
Q8WZ42 | TTN | S4092 | psp | Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14) | Key component in the assembly and functioning of vertebrate striated muscles. By providing connections at the level of individual microfilaments, it contributes to the fine balance of forces between the two halves of the sarcomere. The size and extensibility of the cross-links are the main determinants of sarcomere extensibility properties of muscle. In non-muscle cells, seems to play a role in chromosome condensation and chromosome segregation during mitosis. Might link the lamina network to chromatin or nuclear actin, or both during interphase. {ECO:0000269|PubMed:11846417, ECO:0000269|PubMed:9804419}. |
Q92614 | MYO18A | S1527 | ochoa | Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210) | May link Golgi membranes to the cytoskeleton and participate in the tensile force required for vesicle budding from the Golgi. Thereby, may play a role in Golgi membrane trafficking and could indirectly give its flattened shape to the Golgi apparatus (PubMed:19837035, PubMed:23345592). Alternatively, in concert with LURAP1 and CDC42BPA/CDC42BPB, has been involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). May be involved in the maintenance of the stromal cell architectures required for cell to cell contact (By similarity). Regulates trafficking, expression, and activation of innate immune receptors on macrophages. Plays a role to suppress inflammatory responsiveness of macrophages via a mechanism that modulates CD14 trafficking (PubMed:25965346). Acts as a receptor of surfactant-associated protein A (SFTPA1/SP-A) and plays an important role in internalization and clearance of SFTPA1-opsonized S.aureus by alveolar macrophages (PubMed:16087679, PubMed:21123169). Strongly enhances natural killer cell cytotoxicity (PubMed:27467939). {ECO:0000250|UniProtKB:Q9JMH9, ECO:0000269|PubMed:16087679, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:19837035, ECO:0000269|PubMed:21123169, ECO:0000269|PubMed:23345592, ECO:0000269|PubMed:25965346, ECO:0000269|PubMed:27467939}. |
Q92622 | RUBCN | S473 | ochoa | Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron) | Inhibits PIK3C3 activity; under basal conditions negatively regulates PI3K complex II (PI3KC3-C2) function in autophagy. Negatively regulates endosome maturation and degradative endocytic trafficking and impairs autophagosome maturation process. Can sequester UVRAG from association with a class C Vps complex (possibly the HOPS complex) and negatively regulates Rab7 activation (PubMed:20974968, PubMed:21062745). {ECO:0000269|PubMed:20974968, ECO:0000269|PubMed:21062745}.; FUNCTION: Involved in regulation of pathogen-specific host defense of activated macrophages. Following bacterial infection promotes NADH oxidase activity by association with CYBA thereby affecting TLR2 signaling and probably other TLR-NOX pathways. Stabilizes the CYBA:CYBB NADPH oxidase heterodimer, increases its association with TLR2 and its phagosome trafficking to induce antimicrobial burst of ROS and production of inflammatory cytokines (PubMed:22423966). Following fungal or viral infection (implicating CLEC7A (dectin-1)-mediated myeloid cell activation or RIGI-dependent sensing of RNA viruses) negatively regulates pro-inflammatory cytokine production by association with CARD9 and sequestering it from signaling complexes (PubMed:22423967). {ECO:0000269|PubMed:22423966, ECO:0000269|PubMed:22423967}. |
Q92833 | JARID2 | S821 | ochoa | Protein Jumonji (Jumonji/ARID domain-containing protein 2) | Regulator of histone methyltransferase complexes that plays an essential role in embryonic development, including heart and liver development, neural tube fusion process and hematopoiesis (PubMed:20075857). Acts as an accessory subunit for the core PRC2 (Polycomb repressive complex 2) complex, which mediates histone H3K27 (H3K27me3) trimethylation on chromatin (PubMed:20075857, PubMed:29499137, PubMed:31959557). Binds DNA and mediates the recruitment of the PRC2 complex to target genes in embryonic stem cells, thereby playing a key role in stem cell differentiation and normal embryonic development (PubMed:20075857). In cardiac cells, it is required to repress expression of cyclin-D1 (CCND1) by activating methylation of 'Lys-9' of histone H3 (H3K9me) by the GLP1/EHMT1 and G9a/EHMT2 histone methyltransferases (By similarity). Also acts as a transcriptional repressor of ANF via its interaction with GATA4 and NKX2-5 (By similarity). Participates in the negative regulation of cell proliferation signaling (By similarity). Does not have histone demethylase activity (By similarity). {ECO:0000250|UniProtKB:Q62315, ECO:0000269|PubMed:20075857, ECO:0000269|PubMed:29499137, ECO:0000269|PubMed:31959557}. |
Q96HH9 | GRAMD2B | S29 | ochoa | GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2) | None |
Q96NB3 | ZNF830 | S100 | ochoa | Zinc finger protein 830 (Coiled-coil domain-containing protein 16) | May play a role in pre-mRNA splicing as component of the spliceosome (PubMed:25599396). Acts as an important regulator of the cell cycle that participates in the maintenance of genome integrity. During cell cycle progression in embryonic fibroblast, prevents replication fork collapse, double-strand break formation and cell cycle checkpoint activation. Controls mitotic cell cycle progression and cell survival in rapidly proliferating intestinal epithelium and embryonic stem cells. During the embryo preimplantation, controls different aspects of M phase. During early oocyte growth, plays a role in oocyte survival by preventing chromosomal breaks formation, activation of TP63 and reduction of transcription (By similarity). {ECO:0000250|UniProtKB:Q8R1N0, ECO:0000305|PubMed:25599396}. |
Q96RT1 | ERBIN | S603 | ochoa | Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2) | Acts as an adapter for the receptor ERBB2, in epithelia. By binding the unphosphorylated 'Tyr-1248' of receptor ERBB2, it may contribute to stabilize this unphosphorylated state (PubMed:16203728). Inhibits NOD2-dependent NF-kappa-B signaling and pro-inflammatory cytokine secretion (PubMed:16203728). {ECO:0000269|PubMed:10878805, ECO:0000269|PubMed:16203728}. |
Q99575 | POP1 | S371 | ochoa | Ribonucleases P/MRP protein subunit POP1 (hPOP1) | Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends (PubMed:30454648, PubMed:8918471). Also a component of the MRP ribonuclease complex, which cleaves pre-rRNA sequences (PubMed:28115465). {ECO:0000269|PubMed:28115465, ECO:0000269|PubMed:30454648, ECO:0000269|PubMed:8918471}. |
Q99615 | DNAJC7 | S393 | ochoa | DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2) | Acts as a co-chaperone regulating the molecular chaperones HSP70 and HSP90 in folding of steroid receptors, such as the glucocorticoid receptor and the progesterone receptor. Proposed to act as a recycling chaperone by facilitating the return of chaperone substrates to early stages of chaperoning if further folding is required. In vitro, induces ATP-independent dissociation of HSP90 but not of HSP70 from the chaperone-substrate complexes. Recruits NR1I3 to the cytoplasm (By similarity). {ECO:0000250, ECO:0000269|PubMed:12853476, ECO:0000269|PubMed:18620420}. |
Q99816 | TSG101 | S309 | ochoa | Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101) | Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs). Mediates the association between the ESCRT-0 and ESCRT-I complex. Required for completion of cytokinesis; the function requires CEP55. May be involved in cell growth and differentiation. Acts as a negative growth regulator. Involved in the budding of many viruses through an interaction with viral proteins that contain a late-budding motif P-[ST]-A-P. This interaction is essential for viral particle budding of numerous retroviruses. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). It may also play a role in the extracellular release of microvesicles that differ from the exosomes (PubMed:22315426). {ECO:0000269|PubMed:11916981, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:21070952, ECO:0000269|PubMed:21757351, ECO:0000269|PubMed:22315426, ECO:0000269|PubMed:22660413}. |
Q9BW91 | NUDT9 | S118 | ochoa | ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9) | Hydrolyzes ADP-ribose (ADPR) to AMP and ribose 5'-phosphate. {ECO:0000269|PubMed:11385575}. |
Q9BYW2 | SETD2 | S939 | ochoa | Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP) | Histone methyltransferase that specifically trimethylates 'Lys-36' of histone H3 (H3K36me3) using dimethylated 'Lys-36' (H3K36me2) as substrate (PubMed:16118227, PubMed:19141475, PubMed:21526191, PubMed:21792193, PubMed:23043551, PubMed:27474439). It is capable of trimethylating unmethylated H3K36 (H3K36me0) in vitro (PubMed:19332550). Represents the main enzyme generating H3K36me3, a specific tag for epigenetic transcriptional activation (By similarity). Plays a role in chromatin structure modulation during elongation by coordinating recruitment of the FACT complex and by interacting with hyperphosphorylated POLR2A (PubMed:23325844). Acts as a key regulator of DNA mismatch repair in G1 and early S phase by generating H3K36me3, a mark required to recruit MSH6 subunit of the MutS alpha complex: early recruitment of the MutS alpha complex to chromatin to be replicated allows a quick identification of mismatch DNA to initiate the mismatch repair reaction (PubMed:23622243). Required for DNA double-strand break repair in response to DNA damage: acts by mediating formation of H3K36me3, promoting recruitment of RAD51 and DNA repair via homologous recombination (HR) (PubMed:24843002). Acts as a tumor suppressor (PubMed:24509477). H3K36me3 also plays an essential role in the maintenance of a heterochromatic state, by recruiting DNA methyltransferase DNMT3A (PubMed:27317772). H3K36me3 is also enhanced in intron-containing genes, suggesting that SETD2 recruitment is enhanced by splicing and that splicing is coupled to recruitment of elongating RNA polymerase (PubMed:21792193). Required during angiogenesis (By similarity). Required for endoderm development by promoting embryonic stem cell differentiation toward endoderm: acts by mediating formation of H3K36me3 in distal promoter regions of FGFR3, leading to regulate transcription initiation of FGFR3 (By similarity). In addition to histones, also mediates methylation of other proteins, such as tubulins and STAT1 (PubMed:27518565, PubMed:28753426). Trimethylates 'Lys-40' of alpha-tubulins such as TUBA1B (alpha-TubK40me3); alpha-TubK40me3 is required for normal mitosis and cytokinesis and may be a specific tag in cytoskeletal remodeling (PubMed:27518565). Involved in interferon-alpha-induced antiviral defense by mediating both monomethylation of STAT1 at 'Lys-525' and catalyzing H3K36me3 on promoters of some interferon-stimulated genes (ISGs) to activate gene transcription (PubMed:28753426). {ECO:0000250|UniProtKB:E9Q5F9, ECO:0000269|PubMed:16118227, ECO:0000269|PubMed:19141475, ECO:0000269|PubMed:21526191, ECO:0000269|PubMed:21792193, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:23325844, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:24509477, ECO:0000269|PubMed:24843002, ECO:0000269|PubMed:27317772, ECO:0000269|PubMed:27474439, ECO:0000269|PubMed:27518565, ECO:0000269|PubMed:28753426}.; FUNCTION: (Microbial infection) Recruited to the promoters of adenovirus 12 E1A gene in case of infection, possibly leading to regulate its expression. {ECO:0000269|PubMed:11461154}. |
Q9BZ29 | DOCK9 | S927 | ochoa | Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) | Guanine nucleotide-exchange factor (GEF) that activates CDC42 by exchanging bound GDP for free GTP. Overexpression induces filopodia formation. {ECO:0000269|PubMed:12172552, ECO:0000269|PubMed:19745154}. |
Q9BZI7 | UPF3B | S416 | ochoa | Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B) (hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X) (hUpf3p-X) | Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by associating with the nuclear exon junction complex (EJC) and serving as link between the EJC core and NMD machinery. Recruits UPF2 at the cytoplasmic side of the nuclear envelope and the subsequent formation of an UPF1-UPF2-UPF3 surveillance complex (including UPF1 bound to release factors at the stalled ribosome) is believed to activate NMD. In cooperation with UPF2 stimulates both ATPase and RNA helicase activities of UPF1. Binds spliced mRNA upstream of exon-exon junctions. In vitro, stimulates translation; the function is independent of association with UPF2 and components of the EJC core. {ECO:0000269|PubMed:11163187, ECO:0000269|PubMed:12718880, ECO:0000269|PubMed:16209946, ECO:0000269|PubMed:16601204, ECO:0000269|PubMed:18066079}. |
Q9C0B0 | UNK | S447 | ochoa | RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) | Sequence-specific RNA-binding protein which plays an important role in the establishment and maintenance of the early morphology of cortical neurons during embryonic development. Acts as a translation repressor and controls a translationally regulated cell morphology program to ensure proper structuring of the nervous system. Translational control depends on recognition of its binding element within target mRNAs which consists of a mandatory UAG trimer upstream of a U/A-rich motif. Associated with polysomes (PubMed:25737280). {ECO:0000269|PubMed:25737280}. |
Q9C0B9 | ZCCHC2 | S490 | ochoa | Zinc finger CCHC domain-containing protein 2 | None |
Q9HAW4 | CLSPN | S958 | ochoa | Claspin (hClaspin) | Required for checkpoint mediated cell cycle arrest in response to inhibition of DNA replication or to DNA damage induced by both ionizing and UV irradiation (PubMed:12766152, PubMed:15190204, PubMed:15707391, PubMed:16123041). Adapter protein which binds to BRCA1 and the checkpoint kinase CHEK1 and facilitates the ATR-dependent phosphorylation of both proteins (PubMed:12766152, PubMed:15096610, PubMed:15707391, PubMed:16123041). Also required to maintain normal rates of replication fork progression during unperturbed DNA replication. Binds directly to DNA, with particular affinity for branched or forked molecules and interacts with multiple protein components of the replisome such as the MCM2-7 complex and TIMELESS (PubMed:15226314, PubMed:34694004, PubMed:35585232). Important for initiation of DNA replication, recruits kinase CDC7 to phosphorylate MCM2-7 components (PubMed:27401717). {ECO:0000269|PubMed:12766152, ECO:0000269|PubMed:15096610, ECO:0000269|PubMed:15190204, ECO:0000269|PubMed:15226314, ECO:0000269|PubMed:15707391, ECO:0000269|PubMed:16123041, ECO:0000269|PubMed:27401717, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:35585232}. |
Q9NP61 | ARFGAP3 | S212 | ochoa | ADP-ribosylation factor GTPase-activating protein 3 (ARF GAP 3) | GTPase-activating protein (GAP) for ADP ribosylation factor 1 (ARF1). Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes. {ECO:0000269|PubMed:11172815}. |
Q9NQ92 | COPRS | S138 | ochoa | Coordinator of PRMT5 and differentiation stimulator (Cooperator of PRMT5) (Protein TTP1) | Histone-binding protein required for histone H4 methyltransferase activity of PRMT5. Specifically required for histone H4 'Arg-3' methylation mediated by PRMT5, but not histone H3 'Arg-8' methylation, suggesting that it modulates the substrate specificity of PRMT5. Specifically interacts with the N-terminus of histone H4 but not with histone H3, suggesting that it acts by promoting the association between histone H4 and PRMT5. Involved in CCNE1 promoter repression. Plays a role in muscle cell differentiation by modulating the recruitment of PRMT5 to the promoter of genes involved in the coordination between cell cycle exit and muscle differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:18404153}. |
Q9NSV4 | DIAPH3 | S1127 | ochoa | Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (MDia2) | Actin nucleation and elongation factor required for the assembly of F-actin structures, such as actin cables and stress fibers. Required for cytokinesis, stress fiber formation and transcriptional activation of the serum response factor. Binds to GTP-bound form of Rho and to profilin: acts in a Rho-dependent manner to recruit profilin to the membrane, where it promotes actin polymerization. DFR proteins couple Rho and Src tyrosine kinase during signaling and the regulation of actin dynamics. Also acts as an actin nucleation and elongation factor in the nucleus by promoting nuclear actin polymerization inside the nucleus to drive serum-dependent SRF-MRTFA activity. {ECO:0000250|UniProtKB:Q9Z207}. |
Q9NY72 | SCN3B | S196 | ochoa | Sodium channel regulatory subunit beta-3 | Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provokes membrane depolarization, initiating the propagation of electrical signals throughout cells and tissues. The accessory beta subunits participate in localization and functional modulation of the Nav channels (PubMed:20558140, PubMed:21051419). Modulates the activity of SCN2A/Nav1.2, causing a hyperpolarizing shift in the voltage-dependence of inactivation of the channel and increasing the fraction of channels operating in the fast gating mode (By similarity). Modulates the activity of SCN5A/Nav1.5 (PubMed:20558140, PubMed:21051419, PubMed:24567321, PubMed:31950564). Could also regulate the atypical sodium channel SCN7A/Nav2.1 (PubMed:35301303). Modulates the activity of SCN10A/Nav1.8, regulating its oligomerization and accelerating the recovery from inactivation (PubMed:14975698). {ECO:0000250|UniProtKB:Q9JK00, ECO:0000269|PubMed:14975698, ECO:0000269|PubMed:20558140, ECO:0000269|PubMed:21051419, ECO:0000269|PubMed:24567321, ECO:0000269|PubMed:31950564, ECO:0000269|PubMed:35301303}. |
Q9UGI8 | TES | S105 | ochoa | Testin (TESS) | Scaffold protein that may play a role in cell adhesion, cell spreading and in the reorganization of the actin cytoskeleton. Plays a role in the regulation of cell proliferation. May act as a tumor suppressor. Inhibits tumor cell growth. {ECO:0000269|PubMed:11420696, ECO:0000269|PubMed:12571287, ECO:0000269|PubMed:12695497}. |
Q9UHP3 | USP25 | S85 | ochoa | Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (USP on chromosome 21) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) | Deubiquitinating enzyme that hydrolyzes ubiquitin moieties conjugated to substrates and thus, functions in various biological processes including inflammation and immune response (PubMed:29518389, PubMed:37683630). Modulates the Wnt/beta-catenin pathway by deubiquitinating and stabilizing tankyrases TNKS1 and TNKS2 (PubMed:28619731, PubMed:30926243, PubMed:38875478). Regulates KEAP1-NRF2 axis in the defense against oxidative assaults by deubiquitinating KEAP1 and protecting it from degradation leading to degradation of the NRF2 transcription factor that is responsible for mounting an anti-oxidation gene expression program (PubMed:37339955). Positively regulates RNA virus-induced innate signaling by interacting with and deubiquitinating ERLIN1 and ERLIN2 (PubMed:37683630). In turn, restricts virus production by regulating cholesterol biosynthetic flux (PubMed:37683630). Acts as a negative regulator of interleukin-17-mediated signaling and inflammation through the removal of 'Lys-63'-linked ubiquitination of TRAF5 and TRAF6 (PubMed:23042150). Prevents the ubiquitination and degradation of TRAF3 to reduce the phosphorylation levels of JNK and P38, the secretion of IL-1B and to induce endotoxin tolerance (PubMed:30579117). {ECO:0000269|PubMed:23042150, ECO:0000269|PubMed:28619731, ECO:0000269|PubMed:29518389, ECO:0000269|PubMed:30579117, ECO:0000269|PubMed:30926243, ECO:0000269|PubMed:37339955, ECO:0000269|PubMed:37683630, ECO:0000269|PubMed:38875478}.; FUNCTION: The muscle-specific isoform (USP25m) may have a role in the regulation of muscular differentiation and function. |
Q9UIG0 | BAZ1B | S508 | ochoa | Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2) | Atypical tyrosine-protein kinase that plays a central role in chromatin remodeling and acts as a transcription regulator (PubMed:19092802). Involved in DNA damage response by phosphorylating 'Tyr-142' of histone H2AX (H2AXY142ph) (PubMed:19092802, PubMed:19234442). H2AXY142ph plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress (PubMed:19092802, PubMed:19234442). Regulatory subunit of the ATP-dependent WICH-1 and WICH-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:11980720, PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). The WICH-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the WICH-5 ISWI chromatin remodeling complex (PubMed:28801535). The WICH-5 ISWI chromatin-remodeling complex regulates the transcription of various genes, has a role in RNA polymerase I transcription (By similarity). Within the B-WICH complex has a role in RNA polymerase III transcription (PubMed:16603771). Mediates the recruitment of the WICH-5 ISWI chromatin remodeling complex to replication foci during DNA replication (PubMed:15543136). {ECO:0000250|UniProtKB:Q9Z277, ECO:0000269|PubMed:11980720, ECO:0000269|PubMed:15543136, ECO:0000269|PubMed:16603771, ECO:0000269|PubMed:19092802, ECO:0000269|PubMed:19234442, ECO:0000269|PubMed:28801535}. |
Q9UKF6 | CPSF3 | S659 | ochoa | Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) | Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. Has endonuclease activity, and functions as an mRNA 3'-end-processing endonuclease (PubMed:30507380). Also involved in the histone 3'-end pre-mRNA processing (PubMed:30507380). U7 snRNP-dependent protein that induces both the 3'-endoribonucleolytic cleavage of histone pre-mRNAs and acts as a 5' to 3' exonuclease for degrading the subsequent downstream cleavage product (DCP) of mature histone mRNAs. Cleavage occurs after the 5'-ACCCA-3' sequence in the histone pre-mRNA leaving a 3'hydroxyl group on the upstream fragment containing the stem loop (SL) and 5' phosphate on the downstream cleavage product (DCP) starting with CU nucleotides. The U7-dependent 5' to 3' exonuclease activity is processive and degrades the DCP RNA substrate even after complete removal of the U7-binding site. Binds to the downstream cleavage product (DCP) of histone pre-mRNAs and the cleaved DCP RNA substrate in a U7 snRNP dependent manner. Required for entering/progressing through S-phase of the cell cycle (PubMed:30507380). Required for the selective processing of microRNAs (miRNAs) during embryonic stem cell differentiation via its interaction with ISY1 (By similarity). Required for the biogenesis of all miRNAs from the pri-miR-17-92 primary transcript except miR-92a (By similarity). Only required for the biogenesis of miR-290 and miR-96 from the pri-miR-290-295 and pri-miR-96-183 primary transcripts, respectively (By similarity). {ECO:0000250|UniProtKB:Q9QXK7, ECO:0000269|PubMed:14749727, ECO:0000269|PubMed:15037765, ECO:0000269|PubMed:17128255, ECO:0000269|PubMed:18688255, ECO:0000269|PubMed:30507380}. |
Q9UKL3 | CASP8AP2 | S928 | ochoa | CASP8-associated protein 2 (FLICE-associated huge protein) | Participates in TNF-alpha-induced blockade of glucocorticoid receptor (GR) transactivation at the nuclear receptor coactivator level, upstream and independently of NF-kappa-B. Suppresses both NCOA2- and NCOA3-induced enhancement of GR transactivation. Involved in TNF-alpha-induced activation of NF-kappa-B via a TRAF2-dependent pathway. Acts as a downstream mediator for CASP8-induced activation of NF-kappa-B. Required for the activation of CASP8 in FAS-mediated apoptosis. Required for histone gene transcription and progression through S phase. {ECO:0000269|PubMed:12477726, ECO:0000269|PubMed:15698540, ECO:0000269|PubMed:17003125, ECO:0000269|PubMed:17245429}. |
Q9ULW0 | TPX2 | S634 | ochoa | Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2) (DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100) (p100) | Spindle assembly factor required for normal assembly of mitotic spindles. Required for normal assembly of microtubules during apoptosis. Required for chromatin and/or kinetochore dependent microtubule nucleation. Mediates AURKA localization to spindle microtubules (PubMed:18663142, PubMed:19208764, PubMed:37728657). Activates AURKA by promoting its autophosphorylation at 'Thr-288' and protects this residue against dephosphorylation (PubMed:18663142, PubMed:19208764). TPX2 is inactivated upon binding to importin-alpha (PubMed:26165940). At the onset of mitosis, GOLGA2 interacts with importin-alpha, liberating TPX2 from importin-alpha, allowing TPX2 to activate AURKA kinase and stimulate local microtubule nucleation (PubMed:26165940). {ECO:0000269|PubMed:18663142, ECO:0000269|PubMed:19208764, ECO:0000269|PubMed:26165940}. |
Q9UPN3 | MACF1 | S4521 | ochoa | Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha) | [Isoform 2]: F-actin-binding protein which plays a role in cross-linking actin to other cytoskeletal proteins and also binds to microtubules (PubMed:15265687, PubMed:20937854). Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex (PubMed:20937854). Acts as a positive regulator of Wnt receptor signaling pathway and is involved in the translocation of AXIN1 and its associated complex (composed of APC, CTNNB1 and GSK3B) from the cytoplasm to the cell membrane (By similarity). Has actin-regulated ATPase activity and is essential for controlling focal adhesions (FAs) assembly and dynamics (By similarity). Interaction with CAMSAP3 at the minus ends of non-centrosomal microtubules tethers microtubules minus-ends to actin filaments, regulating focal adhesion size and cell migration (PubMed:27693509). May play role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with GOLGA4 (PubMed:15265687). Plays a key role in wound healing and epidermal cell migration (By similarity). Required for efficient upward migration of bulge cells in response to wounding and this function is primarily rooted in its ability to coordinate microtubule dynamics and polarize hair follicle stem cells (By similarity). As a regulator of actin and microtubule arrangement and stabilization, it plays an essential role in neurite outgrowth, branching and spine formation during brain development (By similarity). {ECO:0000250|UniProtKB:Q9QXZ0, ECO:0000269|PubMed:15265687, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:27693509}. |
Q9UPQ0 | LIMCH1 | S379 | ochoa | LIM and calponin homology domains-containing protein 1 | Actin stress fibers-associated protein that activates non-muscle myosin IIa. Activates the non-muscle myosin IIa complex by promoting the phosphorylation of its regulatory subunit MRLC/MYL9. Through the activation of non-muscle myosin IIa, positively regulates actin stress fibers assembly and stabilizes focal adhesions. It therefore negatively regulates cell spreading and cell migration. {ECO:0000269|PubMed:28228547}. |
Q9UQR1 | ZNF148 | S438 | ochoa | Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89) | Involved in transcriptional regulation. Represses the transcription of a number of genes including gastrin, stromelysin and enolase. Binds to the G-rich box in the enhancer region of these genes. |
Q9Y2F5 | ICE1 | S393 | ochoa | Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1) | Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968, PubMed:23932780). Specifically acts as a scaffold protein that promotes the LEC complex formation and recruitment and RNA polymerase II occupancy at snRNA genes in subnuclear bodies (PubMed:23932780). {ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23932780}. |
Q9Y2H5 | PLEKHA6 | S962 | ochoa | Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3) | None |
Q9Y2K6 | USP20 | S265 | ochoa | Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2) | Deubiquitinating enzyme that plays a role in many cellular processes including autophagy, cellular antiviral response or membrane protein biogenesis (PubMed:27801882, PubMed:29487085). Attenuates TLR4-mediated NF-kappa-B signaling by cooperating with beta-arrestin-2/ARRB2 and inhibiting TRAF6 autoubiquitination (PubMed:26839314). Promotes cellular antiviral responses by deconjugating 'Lys-33' and 'Lys-48'-linked ubiquitination of STING1 leading to its stabilization (PubMed:27801882). Plays an essential role in autophagy induction by regulating the ULK1 stability through deubiquitination of ULK1 (PubMed:29487085). Acts as a positive regulator for NF-kappa-B activation by TNF-alpha through deubiquitinating 'Lys-48'-linked polyubiquitination of SQSTM1, leading to its increased stability (PubMed:32354117). Acts as a regulator of G-protein coupled receptor (GPCR) signaling by mediating the deubiquitination beta-2 adrenergic receptor (ADRB2) (PubMed:19424180). Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2. Upon dissociation, it is probably transferred to the translocated beta-arrestins, possibly leading to beta-arrestins deubiquitination and disengagement from ADRB2 (PubMed:19424180). This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating thyroid hormone regulation. Deubiquitinates HIF1A, leading to stabilize HIF1A and enhance HIF1A-mediated activity (PubMed:15776016). Deubiquitinates MCL1, a pivotal member of the anti-apoptotic Bcl-2 protein family to regulate its stability (PubMed:35063767). Within the endoplasmic reticulum, participates with USP33 in the rescue of post-translationally targeted membrane proteins that are inappropriately ubiquitinated by the cytosolic protein quality control in the cytosol (PubMed:33792613). {ECO:0000269|PubMed:12056827, ECO:0000269|PubMed:12865408, ECO:0000269|PubMed:15776016, ECO:0000269|PubMed:19424180, ECO:0000269|PubMed:26839314, ECO:0000269|PubMed:27801882, ECO:0000269|PubMed:29487085, ECO:0000269|PubMed:32354117, ECO:0000269|PubMed:33792613, ECO:0000269|PubMed:35063767}. |
Q9Y3R5 | DOP1B | S580 | ochoa | Protein DOP1B | May play a role in regulating membrane trafficking of cargo proteins. Together with ATP9A and MON2, regulates SNX3 retromer-mediated endosomal sorting of WLS away from lysosomal degradation. {ECO:0000269|PubMed:30213940}. |
Q9Y496 | KIF3A | S388 | ochoa | Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A) | Microtubule-based anterograde translocator for membranous organelles. Plus end-directed microtubule sliding activity in vitro. Plays a role in primary cilia formation. Plays a role in centriole cohesion and subdistal appendage organization and function. Regulates the formation of the subdistal appendage via recruitment of DCTN1 to the centriole. Also required for ciliary basal feet formation and microtubule anchoring to mother centriole. {ECO:0000250|UniProtKB:P28741}. |
Q9Y4G2 | PLEKHM1 | S305 | ochoa | Pleckstrin homology domain-containing family M member 1 (PH domain-containing family M member 1) (162 kDa adapter protein) (AP162) | Acts as a multivalent adapter protein that regulates Rab7-dependent and HOPS complex-dependent fusion events in the endolysosomal system and couples autophagic and the endocytic trafficking pathways. Acts as a dual effector of RAB7A and ARL8B that simultaneously binds these GTPases, bringing about clustering and fusion of late endosomes and lysosomes (PubMed:25498145, PubMed:28325809). Required for late stages of endolysosomal maturation, facilitating both endocytosis-mediated degradation of growth factor receptors and autophagosome clearance. Interaction with Arl8b is a crucial factor in the terminal maturation of autophagosomes and to mediate autophagosome-lysosome fusion (PubMed:25498145). Positively regulates lysosome peripheral distribution and ruffled border formation in osteoclasts (By similarity). May be involved in negative regulation of endocytic transport from early endosome to late endosome/lysosome implicating its association with Rab7 (PubMed:20943950). May have a role in sialyl-lex-mediated transduction of apoptotic signals (PubMed:12820725). Involved in bone resorption (By similarity). {ECO:0000250|UniProtKB:Q5PQS0, ECO:0000250|UniProtKB:Q7TSI1, ECO:0000269|PubMed:12820725, ECO:0000269|PubMed:20943950, ECO:0000269|PubMed:25498145, ECO:0000269|PubMed:28325809}.; FUNCTION: (Microbial infection) In case of infection contributes to Salmonella typhimurium pathogenesis by supporting the integrity of the Salmonella-containing vacuole (SCV) probably in concert with the HOPS complex and Rab7. {ECO:0000269|PubMed:25500191}. |
P57721 | PCBP3 | S59 | Sugiyama | Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1) | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. {ECO:0000250}. |
P57723 | PCBP4 | S31 | Sugiyama | Poly(rC)-binding protein 4 (Alpha-CP4) | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. {ECO:0000250}. |
Q15365 | PCBP1 | S27 | Sugiyama | Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3) | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC (PubMed:15731341, PubMed:7556077, PubMed:7607214, PubMed:8152927). Together with PCBP2, required for erythropoiesis, possibly by regulating mRNA splicing (By similarity). {ECO:0000250|UniProtKB:P60335, ECO:0000269|PubMed:15731341, ECO:0000269|PubMed:7556077, ECO:0000269|PubMed:7607214, ECO:0000269|PubMed:8152927}.; FUNCTION: (Microbial infection) In case of infection by poliovirus, plays a role in initiation of viral RNA replication in concert with the viral protein 3CD. {ECO:0000269|PubMed:12414943}. |
Q15366 | PCBP2 | S27 | Sugiyama | Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2) | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC (PubMed:12414943, PubMed:7607214). Major cellular poly(rC)-binding protein (PubMed:12414943). Also binds poly(rU) (PubMed:12414943). Acts as a negative regulator of antiviral signaling (PubMed:19881509, PubMed:35322803). Negatively regulates cellular antiviral responses mediated by MAVS signaling (PubMed:19881509). It acts as an adapter between MAVS and the E3 ubiquitin ligase ITCH, therefore triggering MAVS ubiquitination and degradation (PubMed:19881509). Negativeley regulates the cGAS-STING pathway via interaction with CGAS, preventing the formation of liquid-like droplets in which CGAS is activated (PubMed:35322803). Together with PCBP1, required for erythropoiesis, possibly by regulating mRNA splicing (By similarity). {ECO:0000250|UniProtKB:Q61990, ECO:0000269|PubMed:12414943, ECO:0000269|PubMed:19881509, ECO:0000269|PubMed:35322803, ECO:0000269|PubMed:7607214}.; FUNCTION: (Microbial infection) In case of infection by poliovirus, binds to the viral internal ribosome entry site (IRES) and stimulates the IRES-mediated translation (PubMed:12414943, PubMed:24371074). Also plays a role in initiation of viral RNA replication in concert with the viral protein 3CD (PubMed:12414943). {ECO:0000269|PubMed:12414943, ECO:0000269|PubMed:24371074}. |
P14868 | DARS1 | S32 | Sugiyama | Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein) | Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000250|UniProtKB:P15178}. |
Q7L5Y9 | MAEA | S226 | Sugiyama | E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Cell proliferation-inducing gene 5 protein) (Erythroblast macrophage protein) (Human lung cancer oncogene 10 protein) (HLC-10) (Macrophage erythroblast attacher) (P44EMLP) | Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1. MAEA and RMND5A are both required for catalytic activity of the CTLH E3 ubiquitin-protein ligase complex (PubMed:29911972). MAEA is required for normal cell proliferation (PubMed:29911972). The CTLH E3 ubiquitin-protein ligase complex is not required for the degradation of enzymes involved in gluconeogenesis, such as FBP1 (PubMed:29911972). Plays a role in erythroblast enucleation during erythrocyte maturation and in the development of mature macrophages (By similarity). Mediates the attachment of erythroid cell to mature macrophages; this MAEA-mediated contact inhibits erythroid cell apoptosis (PubMed:9763581). Participates in erythroblastic island formation, which is the functional unit of definitive erythropoiesis. Associates with F-actin to regulate actin distribution in erythroblasts and macrophages (By similarity). May contribute to nuclear architecture and cells division events (Probable). {ECO:0000250|UniProtKB:Q4VC33, ECO:0000269|PubMed:29911972, ECO:0000269|PubMed:9763581, ECO:0000305|PubMed:16510120}. |
P17948 | FLT1 | S1031 | Sugiyama | Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) | Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. Acts as a positive regulator of postnatal retinal hyaloid vessel regression (By similarity). May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells. Can promote endothelial cell proliferation, survival and angiogenesis in adulthood. Its function in promoting cell proliferation seems to be cell-type specific. Promotes PGF-mediated proliferation of endothelial cells, proliferation of some types of cancer cells, but does not promote proliferation of normal fibroblasts (in vitro). Has very high affinity for VEGFA and relatively low protein kinase activity; may function as a negative regulator of VEGFA signaling by limiting the amount of free VEGFA and preventing its binding to KDR. Modulates KDR signaling by forming heterodimers with KDR. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leading to activation of phosphatidylinositol kinase and the downstream signaling pathway. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Phosphorylates SRC and YES1, and may also phosphorylate CBL. Promotes phosphorylation of AKT1 at 'Ser-473'. Promotes phosphorylation of PTK2/FAK1 (PubMed:16685275). {ECO:0000250|UniProtKB:P35969, ECO:0000269|PubMed:11141500, ECO:0000269|PubMed:11312102, ECO:0000269|PubMed:11811792, ECO:0000269|PubMed:12796773, ECO:0000269|PubMed:14633857, ECO:0000269|PubMed:15735759, ECO:0000269|PubMed:16685275, ECO:0000269|PubMed:18079407, ECO:0000269|PubMed:18515749, ECO:0000269|PubMed:18583712, ECO:0000269|PubMed:18593464, ECO:0000269|PubMed:20512933, ECO:0000269|PubMed:20551949, ECO:0000269|PubMed:21752276, ECO:0000269|PubMed:7824266, ECO:0000269|PubMed:8248162, ECO:0000269|PubMed:8605350, ECO:0000269|PubMed:9299537, ECO:0000269|Ref.11}.; FUNCTION: [Isoform 1]: Phosphorylates PLCG. {ECO:0000269|PubMed:9299537}.; FUNCTION: [Isoform 2]: May function as decoy receptor for VEGFA. {ECO:0000269|PubMed:21752276}.; FUNCTION: [Isoform 3]: May function as decoy receptor for VEGFA. {ECO:0000269|PubMed:21752276}.; FUNCTION: [Isoform 4]: May function as decoy receptor for VEGFA. {ECO:0000269|PubMed:21752276}.; FUNCTION: [Isoform 7]: Has a truncated kinase domain; it increases phosphorylation of SRC at 'Tyr-418' by unknown means and promotes tumor cell invasion. {ECO:0000269|PubMed:20512933}. |
P35916 | FLT4 | S1046 | Sugiyama | Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) | Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Promotes phosphorylation of MAPK8 at 'Thr-183' and 'Tyr-185', and of AKT1 at 'Ser-473'. {ECO:0000269|PubMed:11532940, ECO:0000269|PubMed:15102829, ECO:0000269|PubMed:15474514, ECO:0000269|PubMed:16076871, ECO:0000269|PubMed:16452200, ECO:0000269|PubMed:17210781, ECO:0000269|PubMed:19610651, ECO:0000269|PubMed:19779139, ECO:0000269|PubMed:20224550, ECO:0000269|PubMed:20431062, ECO:0000269|PubMed:20445537, ECO:0000269|PubMed:21273538, ECO:0000269|PubMed:7675451, ECO:0000269|PubMed:8700872, ECO:0000269|PubMed:9435229}. |
Q86U86 | PBRM1 | S267 | Sugiyama | Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. {ECO:0000269|PubMed:21248752, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
P10809 | HSPD1 | S159 | Sugiyama | 60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (Heat shock protein family D member 1) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein) | Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:11422376, PubMed:1346131). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein (Probable). {ECO:0000269|PubMed:11422376, ECO:0000269|PubMed:1346131, ECO:0000305|PubMed:25918392}. |
Q01082 | SPTBN1 | S1666 | Sugiyama | Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1) | Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane. Plays a critical role in central nervous system development and function. {ECO:0000269|PubMed:34211179}. |
P63151 | PPP2R2A | S113 | Sugiyama | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (B55) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha) | Substrate-recognition subunit of protein phosphatase 2A (PP2A) that plays a key role in cell cycle by controlling mitosis entry and exit (PubMed:1849734, PubMed:33108758). Involved in chromosome clustering during late mitosis by mediating dephosphorylation of MKI67 (By similarity). Essential for serine/threonine-protein phosphatase 2A-mediated dephosphorylation of WEE1, preventing its ubiquitin-mediated proteolysis, increasing WEE1 protein levels, and promoting the G2/M checkpoint (PubMed:33108758). {ECO:0000250|UniProtKB:Q6P1F6, ECO:0000269|PubMed:1849734, ECO:0000269|PubMed:33108758}. |
P17987 | TCP1 | S119 | Sugiyama | T-complex protein 1 subunit alpha (TCP-1-alpha) (EC 3.6.1.-) (CCT-alpha) (Chaperonin containing T-complex polypeptide 1 subunit 1) | Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of actin, tubulin and other proteins upon ATP hydrolysis (PubMed:25467444, PubMed:36493755, PubMed:35449234, PubMed:37193829). The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance (PubMed:25467444). As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (PubMed:20080638). {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444, ECO:0000269|PubMed:35449234, ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-390522 | Striated Muscle Contraction | 6.768140e-08 | 7.170 |
R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) | 4.005379e-08 | 7.397 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 8.974556e-07 | 6.047 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 8.282964e-06 | 5.082 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 1.078298e-05 | 4.967 |
R-HSA-445355 | Smooth Muscle Contraction | 1.589060e-05 | 4.799 |
R-HSA-9764561 | Regulation of CDH1 Function | 2.262576e-05 | 4.645 |
R-HSA-397014 | Muscle contraction | 3.353775e-05 | 4.474 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 8.042008e-05 | 4.095 |
R-HSA-373760 | L1CAM interactions | 1.377441e-04 | 3.861 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 2.818076e-04 | 3.550 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 3.391760e-04 | 3.470 |
R-HSA-75153 | Apoptotic execution phase | 1.245797e-03 | 2.905 |
R-HSA-69481 | G2/M Checkpoints | 1.446027e-03 | 2.840 |
R-HSA-3247509 | Chromatin modifying enzymes | 1.585516e-03 | 2.800 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 1.671084e-03 | 2.777 |
R-HSA-195399 | VEGF binds to VEGFR leading to receptor dimerization | 2.199016e-03 | 2.658 |
R-HSA-194313 | VEGF ligand-receptor interactions | 2.199016e-03 | 2.658 |
R-HSA-8935964 | RUNX1 regulates expression of components of tight junctions | 2.199016e-03 | 2.658 |
R-HSA-4839726 | Chromatin organization | 2.258160e-03 | 2.646 |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | 2.697461e-03 | 2.569 |
R-HSA-8869496 | TFAP2A acts as a transcriptional repressor during retinoic acid induced cell dif... | 2.767705e-03 | 2.558 |
R-HSA-68962 | Activation of the pre-replicative complex | 3.747229e-03 | 2.426 |
R-HSA-196025 | Formation of annular gap junctions | 4.088815e-03 | 2.388 |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | 4.088815e-03 | 2.388 |
R-HSA-190873 | Gap junction degradation | 4.839111e-03 | 2.315 |
R-HSA-176187 | Activation of ATR in response to replication stress | 4.677144e-03 | 2.330 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 5.291598e-03 | 2.276 |
R-HSA-9013694 | Signaling by NOTCH4 | 5.521910e-03 | 2.258 |
R-HSA-390450 | Folding of actin by CCT/TriC | 5.647842e-03 | 2.248 |
R-HSA-9682385 | FLT3 signaling in disease | 6.116733e-03 | 2.213 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 6.275605e-03 | 2.202 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 6.275605e-03 | 2.202 |
R-HSA-3214841 | PKMTs methylate histone lysines | 8.251274e-03 | 2.083 |
R-HSA-1640170 | Cell Cycle | 9.588553e-03 | 2.018 |
R-HSA-74160 | Gene expression (Transcription) | 9.361192e-03 | 2.029 |
R-HSA-69620 | Cell Cycle Checkpoints | 1.006528e-02 | 1.997 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 1.053243e-02 | 1.977 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 1.057973e-02 | 1.976 |
R-HSA-446353 | Cell-extracellular matrix interactions | 1.167060e-02 | 1.933 |
R-HSA-199991 | Membrane Trafficking | 1.213175e-02 | 1.916 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 1.247702e-02 | 1.904 |
R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 1.286026e-02 | 1.891 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 1.362378e-02 | 1.866 |
R-HSA-5545483 | Defective Mismatch Repair Associated With MLH1 | 1.687256e-02 | 1.773 |
R-HSA-5632987 | Defective Mismatch Repair Associated With PMS2 | 1.687256e-02 | 1.773 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 1.594034e-02 | 1.798 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 1.672890e-02 | 1.777 |
R-HSA-73894 | DNA Repair | 1.648436e-02 | 1.783 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 1.773806e-02 | 1.751 |
R-HSA-418990 | Adherens junctions interactions | 1.665471e-02 | 1.778 |
R-HSA-73857 | RNA Polymerase II Transcription | 1.871290e-02 | 1.728 |
R-HSA-109581 | Apoptosis | 1.940820e-02 | 1.712 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 1.998326e-02 | 1.699 |
R-HSA-9665230 | Drug resistance in ERBB2 KD mutants | 3.346247e-02 | 1.475 |
R-HSA-9652282 | Drug-mediated inhibition of ERBB2 signaling | 3.346247e-02 | 1.475 |
R-HSA-9665250 | Resistance of ERBB2 KD mutants to AEE788 | 3.346247e-02 | 1.475 |
R-HSA-9665249 | Resistance of ERBB2 KD mutants to afatinib | 3.346247e-02 | 1.475 |
R-HSA-9665246 | Resistance of ERBB2 KD mutants to neratinib | 3.346247e-02 | 1.475 |
R-HSA-9665244 | Resistance of ERBB2 KD mutants to sapitinib | 3.346247e-02 | 1.475 |
R-HSA-9665247 | Resistance of ERBB2 KD mutants to osimertinib | 3.346247e-02 | 1.475 |
R-HSA-9665737 | Drug resistance in ERBB2 TMD/JMD mutants | 3.346247e-02 | 1.475 |
R-HSA-9665251 | Resistance of ERBB2 KD mutants to lapatinib | 3.346247e-02 | 1.475 |
R-HSA-9665245 | Resistance of ERBB2 KD mutants to tesevatinib | 3.346247e-02 | 1.475 |
R-HSA-9665233 | Resistance of ERBB2 KD mutants to trastuzumab | 3.346247e-02 | 1.475 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 2.573329e-02 | 1.590 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 2.492252e-02 | 1.603 |
R-HSA-5693606 | DNA Double Strand Break Response | 2.670198e-02 | 1.573 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 3.045978e-02 | 1.516 |
R-HSA-194306 | Neurophilin interactions with VEGF and VEGFR | 3.346247e-02 | 1.475 |
R-HSA-212165 | Epigenetic regulation of gene expression | 2.802469e-02 | 1.552 |
R-HSA-352238 | Breakdown of the nuclear lamina | 2.520255e-02 | 1.599 |
R-HSA-69473 | G2/M DNA damage checkpoint | 3.345134e-02 | 1.476 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 2.908474e-02 | 1.536 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 2.908474e-02 | 1.536 |
R-HSA-69052 | Switching of origins to a post-replicative state | 3.243773e-02 | 1.489 |
R-HSA-9841251 | Mitochondrial unfolded protein response (UPRmt) | 3.260008e-02 | 1.487 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 2.761660e-02 | 1.559 |
R-HSA-1474244 | Extracellular matrix organization | 3.117905e-02 | 1.506 |
R-HSA-194138 | Signaling by VEGF | 3.232515e-02 | 1.490 |
R-HSA-1500931 | Cell-Cell communication | 2.544929e-02 | 1.594 |
R-HSA-421270 | Cell-cell junction organization | 2.904645e-02 | 1.537 |
R-HSA-9944997 | Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | 4.165291e-02 | 1.380 |
R-HSA-9944971 | Loss of Function of KMT2D in Kabuki Syndrome | 4.165291e-02 | 1.380 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 3.627292e-02 | 1.440 |
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 4.009702e-02 | 1.397 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 3.622468e-02 | 1.441 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 4.100251e-02 | 1.387 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 3.836827e-02 | 1.416 |
R-HSA-5423599 | Diseases of Mismatch Repair (MMR) | 4.165291e-02 | 1.380 |
R-HSA-390650 | Histamine receptors | 4.165291e-02 | 1.380 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 4.001447e-02 | 1.398 |
R-HSA-9659379 | Sensory processing of sound | 3.876413e-02 | 1.412 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 4.030947e-02 | 1.395 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 3.987528e-02 | 1.399 |
R-HSA-446728 | Cell junction organization | 4.283308e-02 | 1.368 |
R-HSA-72172 | mRNA Splicing | 4.335073e-02 | 1.363 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 4.341080e-02 | 1.362 |
R-HSA-5357801 | Programmed Cell Death | 4.403752e-02 | 1.356 |
R-HSA-212436 | Generic Transcription Pathway | 4.499370e-02 | 1.347 |
R-HSA-6802957 | Oncogenic MAPK signaling | 4.567090e-02 | 1.340 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 5.458641e-02 | 1.263 |
R-HSA-5674135 | MAP2K and MAPK activation | 6.588929e-02 | 1.181 |
R-HSA-68867 | Assembly of the pre-replicative complex | 5.843323e-02 | 1.233 |
R-HSA-9656223 | Signaling by RAF1 mutants | 6.588929e-02 | 1.181 |
R-HSA-68689 | CDC6 association with the ORC:origin complex | 6.581311e-02 | 1.182 |
R-HSA-6807878 | COPI-mediated anterograde transport | 6.396106e-02 | 1.194 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 5.321987e-02 | 1.274 |
R-HSA-69560 | Transcriptional activation of p53 responsive genes | 4.977445e-02 | 1.303 |
R-HSA-69895 | Transcriptional activation of cell cycle inhibitor p21 | 4.977445e-02 | 1.303 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 5.027963e-02 | 1.299 |
R-HSA-9758919 | Epithelial-Mesenchymal Transition (EMT) during gastrulation | 6.581311e-02 | 1.182 |
R-HSA-5653656 | Vesicle-mediated transport | 5.097268e-02 | 1.293 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 5.997550e-02 | 1.222 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 5.227075e-02 | 1.282 |
R-HSA-422475 | Axon guidance | 5.341205e-02 | 1.272 |
R-HSA-8957275 | Post-translational protein phosphorylation | 6.681269e-02 | 1.175 |
R-HSA-3214858 | RMTs methylate histone arginines | 7.301225e-02 | 1.137 |
R-HSA-190828 | Gap junction trafficking | 7.301225e-02 | 1.137 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 7.301225e-02 | 1.137 |
R-HSA-3928662 | EPHB-mediated forward signaling | 7.301225e-02 | 1.137 |
R-HSA-9675108 | Nervous system development | 7.307102e-02 | 1.136 |
R-HSA-113507 | E2F-enabled inhibition of pre-replication complex formation | 7.373137e-02 | 1.132 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 7.570896e-02 | 1.121 |
R-HSA-72187 | mRNA 3'-end processing | 9.311290e-02 | 1.031 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 9.572812e-02 | 1.019 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 1.145917e-01 | 0.941 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 8.997291e-02 | 1.046 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 8.997291e-02 | 1.046 |
R-HSA-9664873 | Pexophagy | 1.047437e-01 | 0.980 |
R-HSA-69002 | DNA Replication Pre-Initiation | 8.509961e-02 | 1.070 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 9.328560e-02 | 1.030 |
R-HSA-5620924 | Intraflagellar transport | 8.287254e-02 | 1.082 |
R-HSA-5693538 | Homology Directed Repair | 1.035197e-01 | 0.985 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 7.789255e-02 | 1.109 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 7.789255e-02 | 1.109 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 7.789255e-02 | 1.109 |
R-HSA-176974 | Unwinding of DNA | 9.708859e-02 | 1.013 |
R-HSA-6802949 | Signaling by RAS mutants | 7.789255e-02 | 1.109 |
R-HSA-9948001 | CASP4 inflammasome assembly | 1.047437e-01 | 0.980 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 1.123343e-01 | 0.949 |
R-HSA-3214815 | HDACs deacetylate histones | 1.010209e-01 | 0.996 |
R-HSA-428359 | Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RN... | 1.047437e-01 | 0.980 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 8.539844e-02 | 1.069 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 8.539844e-02 | 1.069 |
R-HSA-983189 | Kinesins | 1.145917e-01 | 0.941 |
R-HSA-68949 | Orc1 removal from chromatin | 9.311290e-02 | 1.031 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 1.063931e-01 | 0.973 |
R-HSA-437239 | Recycling pathway of L1 | 8.037038e-02 | 1.095 |
R-HSA-9675135 | Diseases of DNA repair | 7.789255e-02 | 1.109 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 9.328560e-02 | 1.030 |
R-HSA-69239 | Synthesis of DNA | 8.191591e-02 | 1.087 |
R-HSA-8953854 | Metabolism of RNA | 1.138556e-01 | 0.944 |
R-HSA-157858 | Gap junction trafficking and regulation | 8.539844e-02 | 1.069 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 8.474613e-02 | 1.072 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 8.037038e-02 | 1.095 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 1.063931e-01 | 0.973 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 9.496075e-02 | 1.022 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 1.198610e-01 | 0.921 |
R-HSA-9931512 | Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | 1.198610e-01 | 0.921 |
R-HSA-77595 | Processing of Intronless Pre-mRNAs | 1.637093e-01 | 0.786 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 1.848131e-01 | 0.733 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 1.917296e-01 | 0.717 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 1.917296e-01 | 0.717 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 1.917296e-01 | 0.717 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 1.917296e-01 | 0.717 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 1.917296e-01 | 0.717 |
R-HSA-389960 | Formation of tubulin folding intermediates by CCT/TriC | 2.254476e-01 | 0.647 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 2.320217e-01 | 0.634 |
R-HSA-390466 | Chaperonin-mediated protein folding | 1.970389e-01 | 0.705 |
R-HSA-3000157 | Laminin interactions | 2.320217e-01 | 0.634 |
R-HSA-9931521 | The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CL... | 1.637093e-01 | 0.786 |
R-HSA-391251 | Protein folding | 2.156000e-01 | 0.666 |
R-HSA-5358508 | Mismatch Repair | 1.778379e-01 | 0.750 |
R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 | 1.273244e-01 | 0.895 |
R-HSA-174490 | Membrane binding and targetting of GAG proteins | 1.347249e-01 | 0.871 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 1.347249e-01 | 0.871 |
R-HSA-5358565 | Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 1.708035e-01 | 0.768 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 2.254476e-01 | 0.647 |
R-HSA-9865881 | Complex III assembly | 2.254476e-01 | 0.647 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 1.173599e-01 | 0.930 |
R-HSA-1236974 | ER-Phagosome pathway | 2.032049e-01 | 0.692 |
R-HSA-5358606 | Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 1.708035e-01 | 0.768 |
R-HSA-1839117 | Signaling by cytosolic FGFR1 fusion mutants | 1.778379e-01 | 0.750 |
R-HSA-1268020 | Mitochondrial protein import | 1.201449e-01 | 0.920 |
R-HSA-174495 | Synthesis And Processing Of GAG, GAGPOL Polyproteins | 1.420632e-01 | 0.848 |
R-HSA-111447 | Activation of BAD and translocation to mitochondria | 1.493396e-01 | 0.826 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 1.786980e-01 | 0.748 |
R-HSA-69306 | DNA Replication | 1.791770e-01 | 0.747 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 1.371832e-01 | 0.863 |
R-HSA-5693548 | Sensing of DNA Double Strand Breaks | 1.198610e-01 | 0.921 |
R-HSA-9018681 | Biosynthesis of protectins | 1.420632e-01 | 0.848 |
R-HSA-1500620 | Meiosis | 1.878365e-01 | 0.726 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 2.254476e-01 | 0.647 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 1.778379e-01 | 0.750 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 1.206190e-01 | 0.919 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 1.848131e-01 | 0.733 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 1.488211e-01 | 0.827 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 1.726458e-01 | 0.763 |
R-HSA-5635838 | Activation of SMO | 1.565548e-01 | 0.805 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 1.229464e-01 | 0.910 |
R-HSA-9612973 | Autophagy | 1.855269e-01 | 0.732 |
R-HSA-75035 | Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 1.347249e-01 | 0.871 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 1.420632e-01 | 0.848 |
R-HSA-9755779 | SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 1.493396e-01 | 0.826 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 1.493396e-01 | 0.826 |
R-HSA-9020265 | Biosynthesis of aspirin-triggered D-series resolvins | 1.708035e-01 | 0.768 |
R-HSA-5620922 | BBSome-mediated cargo-targeting to cilium | 1.917296e-01 | 0.717 |
R-HSA-9018676 | Biosynthesis of D-series resolvins | 2.121313e-01 | 0.673 |
R-HSA-9686114 | Non-canonical inflammasome activation | 1.420632e-01 | 0.848 |
R-HSA-9675151 | Disorders of Developmental Biology | 1.637093e-01 | 0.786 |
R-HSA-9755088 | Ribavirin ADME | 2.053882e-01 | 0.687 |
R-HSA-69206 | G1/S Transition | 1.178201e-01 | 0.929 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 1.939649e-01 | 0.712 |
R-HSA-9023661 | Biosynthesis of E-series 18(R)-resolvins | 1.420632e-01 | 0.848 |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 1.493396e-01 | 0.826 |
R-HSA-2161541 | Abacavir metabolism | 1.985877e-01 | 0.702 |
R-HSA-77111 | Synthesis of Ketone Bodies | 1.917296e-01 | 0.717 |
R-HSA-175474 | Assembly Of The HIV Virion | 2.053882e-01 | 0.687 |
R-HSA-9018896 | Biosynthesis of E-series 18(S)-resolvins | 1.985877e-01 | 0.702 |
R-HSA-9629569 | Protein hydroxylation | 1.917296e-01 | 0.717 |
R-HSA-5633007 | Regulation of TP53 Activity | 1.940845e-01 | 0.712 |
R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | 2.053882e-01 | 0.687 |
R-HSA-74182 | Ketone body metabolism | 2.188176e-01 | 0.660 |
R-HSA-69242 | S Phase | 1.687340e-01 | 0.773 |
R-HSA-69278 | Cell Cycle, Mitotic | 1.288408e-01 | 0.890 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 1.778379e-01 | 0.750 |
R-HSA-373753 | Nephrin family interactions | 1.917296e-01 | 0.717 |
R-HSA-5689880 | Ub-specific processing proteases | 2.247517e-01 | 0.648 |
R-HSA-74259 | Purine catabolism | 1.488211e-01 | 0.827 |
R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases | 1.565548e-01 | 0.805 |
R-HSA-5688426 | Deubiquitination | 2.075759e-01 | 0.683 |
R-HSA-8863678 | Neurodegenerative Diseases | 2.254476e-01 | 0.647 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 2.254476e-01 | 0.647 |
R-HSA-2682334 | EPH-Ephrin signaling | 2.156000e-01 | 0.666 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 1.285966e-01 | 0.891 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 1.939649e-01 | 0.712 |
R-HSA-381070 | IRE1alpha activates chaperones | 2.124941e-01 | 0.673 |
R-HSA-157118 | Signaling by NOTCH | 1.817375e-01 | 0.741 |
R-HSA-9020591 | Interleukin-12 signaling | 1.606505e-01 | 0.794 |
R-HSA-447115 | Interleukin-12 family signaling | 1.970389e-01 | 0.705 |
R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock gene... | 2.385405e-01 | 0.622 |
R-HSA-8874081 | MET activates PTK2 signaling | 2.385405e-01 | 0.622 |
R-HSA-9638630 | Attachment of bacteria to epithelial cells | 2.385405e-01 | 0.622 |
R-HSA-70635 | Urea cycle | 2.385405e-01 | 0.622 |
R-HSA-2161522 | Abacavir ADME | 2.385405e-01 | 0.622 |
R-HSA-9614085 | FOXO-mediated transcription | 2.405762e-01 | 0.619 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 2.450043e-01 | 0.611 |
R-HSA-6803204 | TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 2.450043e-01 | 0.611 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 2.499832e-01 | 0.602 |
R-HSA-9842860 | Regulation of endogenous retroelements | 2.499832e-01 | 0.602 |
R-HSA-5576892 | Phase 0 - rapid depolarisation | 2.514136e-01 | 0.600 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 2.577689e-01 | 0.589 |
R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) | 2.577689e-01 | 0.589 |
R-HSA-9615710 | Late endosomal microautophagy | 2.577689e-01 | 0.589 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 2.577689e-01 | 0.589 |
R-HSA-9018679 | Biosynthesis of EPA-derived SPMs | 2.577689e-01 | 0.589 |
R-HSA-597592 | Post-translational protein modification | 2.611942e-01 | 0.583 |
R-HSA-5696398 | Nucleotide Excision Repair | 2.625428e-01 | 0.581 |
R-HSA-5617833 | Cilium Assembly | 2.631334e-01 | 0.580 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 2.640707e-01 | 0.578 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 2.640707e-01 | 0.578 |
R-HSA-114452 | Activation of BH3-only proteins | 2.640707e-01 | 0.578 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 2.656840e-01 | 0.576 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 2.688254e-01 | 0.571 |
R-HSA-9700206 | Signaling by ALK in cancer | 2.688254e-01 | 0.571 |
R-HSA-162588 | Budding and maturation of HIV virion | 2.703193e-01 | 0.568 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 2.703193e-01 | 0.568 |
R-HSA-5694530 | Cargo concentration in the ER | 2.703193e-01 | 0.568 |
R-HSA-1236975 | Antigen processing-Cross presentation | 2.719666e-01 | 0.565 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 2.719666e-01 | 0.565 |
R-HSA-69190 | DNA strand elongation | 2.765153e-01 | 0.558 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 2.826590e-01 | 0.549 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 2.826590e-01 | 0.549 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 2.826590e-01 | 0.549 |
R-HSA-1839124 | FGFR1 mutant receptor activation | 2.826590e-01 | 0.549 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 2.826590e-01 | 0.549 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 2.826590e-01 | 0.549 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 2.826590e-01 | 0.549 |
R-HSA-390471 | Association of TriC/CCT with target proteins during biosynthesis | 2.887509e-01 | 0.539 |
R-HSA-5693537 | Resolution of D-Loop Structures | 2.887509e-01 | 0.539 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 2.887509e-01 | 0.539 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 2.887509e-01 | 0.539 |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | 2.887509e-01 | 0.539 |
R-HSA-5223345 | Miscellaneous transport and binding events | 2.887509e-01 | 0.539 |
R-HSA-6814122 | Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 2.947915e-01 | 0.530 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 2.947915e-01 | 0.530 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 2.947915e-01 | 0.530 |
R-HSA-983170 | Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 2.947915e-01 | 0.530 |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 2.947915e-01 | 0.530 |
R-HSA-901042 | Calnexin/calreticulin cycle | 2.947915e-01 | 0.530 |
R-HSA-2393930 | Phosphate bond hydrolysis by NUDT proteins | 2.947915e-01 | 0.530 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 2.954466e-01 | 0.530 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 3.001963e-01 | 0.523 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 3.007812e-01 | 0.522 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 3.007812e-01 | 0.522 |
R-HSA-212300 | PRC2 methylates histones and DNA | 3.067203e-01 | 0.513 |
R-HSA-6804757 | Regulation of TP53 Degradation | 3.067203e-01 | 0.513 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 3.126094e-01 | 0.505 |
R-HSA-68875 | Mitotic Prophase | 3.158123e-01 | 0.501 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 3.184488e-01 | 0.497 |
R-HSA-9931953 | Biofilm formation | 3.184488e-01 | 0.497 |
R-HSA-8875878 | MET promotes cell motility | 3.184488e-01 | 0.497 |
R-HSA-3371556 | Cellular response to heat stress | 3.189269e-01 | 0.496 |
R-HSA-69541 | Stabilization of p53 | 3.242389e-01 | 0.489 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 3.242389e-01 | 0.489 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 3.242389e-01 | 0.489 |
R-HSA-68882 | Mitotic Anaphase | 3.254523e-01 | 0.488 |
R-HSA-446203 | Asparagine N-linked glycosylation | 3.254788e-01 | 0.487 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 3.277721e-01 | 0.484 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 3.299802e-01 | 0.482 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 3.299802e-01 | 0.482 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 3.299802e-01 | 0.482 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 3.299802e-01 | 0.482 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 3.413180e-01 | 0.467 |
R-HSA-6811438 | Intra-Golgi traffic | 3.413180e-01 | 0.467 |
R-HSA-8956319 | Nucleotide catabolism | 3.467925e-01 | 0.460 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 3.469152e-01 | 0.460 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 3.469152e-01 | 0.460 |
R-HSA-8854214 | TBC/RABGAPs | 3.524653e-01 | 0.453 |
R-HSA-1474165 | Reproduction | 3.529374e-01 | 0.452 |
R-HSA-69236 | G1 Phase | 3.579685e-01 | 0.446 |
R-HSA-69231 | Cyclin D associated events in G1 | 3.579685e-01 | 0.446 |
R-HSA-375280 | Amine ligand-binding receptors | 3.579685e-01 | 0.446 |
R-HSA-2142691 | Synthesis of Leukotrienes (LT) and Eoxins (EX) | 3.579685e-01 | 0.446 |
R-HSA-5683826 | Surfactant metabolism | 3.579685e-01 | 0.446 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 3.634253e-01 | 0.440 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 3.688360e-01 | 0.433 |
R-HSA-9861718 | Regulation of pyruvate metabolism | 3.688360e-01 | 0.433 |
R-HSA-9031628 | NGF-stimulated transcription | 3.795209e-01 | 0.421 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 3.833445e-01 | 0.416 |
R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 3.847958e-01 | 0.415 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 3.863532e-01 | 0.413 |
R-HSA-9664417 | Leishmania phagocytosis | 3.863532e-01 | 0.413 |
R-HSA-9664407 | Parasite infection | 3.863532e-01 | 0.413 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 3.893555e-01 | 0.410 |
R-HSA-1632852 | Macroautophagy | 3.893555e-01 | 0.410 |
R-HSA-912446 | Meiotic recombination | 3.952124e-01 | 0.403 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 3.983236e-01 | 0.400 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 4.003549e-01 | 0.398 |
R-HSA-1221632 | Meiotic synapsis | 4.054539e-01 | 0.392 |
R-HSA-9639288 | Amino acids regulate mTORC1 | 4.054539e-01 | 0.392 |
R-HSA-8953897 | Cellular responses to stimuli | 4.065119e-01 | 0.391 |
R-HSA-9679191 | Potential therapeutics for SARS | 4.190093e-01 | 0.378 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 4.204943e-01 | 0.376 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 4.204943e-01 | 0.376 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 4.248544e-01 | 0.372 |
R-HSA-9609507 | Protein localization | 4.277657e-01 | 0.369 |
R-HSA-6782135 | Dual incision in TC-NER | 4.303107e-01 | 0.366 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 4.303107e-01 | 0.366 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 4.306693e-01 | 0.366 |
R-HSA-9734767 | Developmental Cell Lineages | 4.332397e-01 | 0.363 |
R-HSA-379724 | tRNA Aminoacylation | 4.399620e-01 | 0.357 |
R-HSA-1227986 | Signaling by ERBB2 | 4.399620e-01 | 0.357 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 4.399620e-01 | 0.357 |
R-HSA-162582 | Signal Transduction | 4.426181e-01 | 0.354 |
R-HSA-68886 | M Phase | 4.490681e-01 | 0.348 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 4.494510e-01 | 0.347 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 4.494510e-01 | 0.347 |
R-HSA-6784531 | tRNA processing in the nucleus | 4.494510e-01 | 0.347 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 4.494510e-01 | 0.347 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 4.494510e-01 | 0.347 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 4.509459e-01 | 0.346 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 4.541355e-01 | 0.343 |
R-HSA-8854518 | AURKA Activation by TPX2 | 4.679528e-01 | 0.330 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 4.679528e-01 | 0.330 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 4.724810e-01 | 0.326 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 4.814229e-01 | 0.317 |
R-HSA-204005 | COPII-mediated vesicle transport | 4.858373e-01 | 0.314 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 4.858373e-01 | 0.314 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 4.897565e-01 | 0.310 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 4.902143e-01 | 0.310 |
R-HSA-5632684 | Hedgehog 'on' state | 4.902143e-01 | 0.310 |
R-HSA-3000178 | ECM proteoglycans | 4.902143e-01 | 0.310 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 4.902143e-01 | 0.310 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 4.902143e-01 | 0.310 |
R-HSA-5673001 | RAF/MAP kinase cascade | 4.903173e-01 | 0.310 |
R-HSA-9678108 | SARS-CoV-1 Infection | 4.924751e-01 | 0.308 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 4.945544e-01 | 0.306 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 4.988577e-01 | 0.302 |
R-HSA-1226099 | Signaling by FGFR in disease | 5.031247e-01 | 0.298 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 5.052166e-01 | 0.297 |
R-HSA-392499 | Metabolism of proteins | 5.053906e-01 | 0.296 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 5.073557e-01 | 0.295 |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | 5.073557e-01 | 0.295 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 5.115509e-01 | 0.291 |
R-HSA-5689603 | UCH proteinases | 5.115509e-01 | 0.291 |
R-HSA-1266738 | Developmental Biology | 5.121092e-01 | 0.291 |
R-HSA-73864 | RNA Polymerase I Transcription | 5.198351e-01 | 0.284 |
R-HSA-69275 | G2/M Transition | 5.217740e-01 | 0.283 |
R-HSA-453274 | Mitotic G2-G2/M phases | 5.269796e-01 | 0.278 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 5.279798e-01 | 0.277 |
R-HSA-6806834 | Signaling by MET | 5.279798e-01 | 0.277 |
R-HSA-9018677 | Biosynthesis of DHA-derived SPMs | 5.320006e-01 | 0.274 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 5.438601e-01 | 0.265 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 5.438601e-01 | 0.265 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 5.545393e-01 | 0.256 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 5.554212e-01 | 0.255 |
R-HSA-163841 | Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 5.554212e-01 | 0.255 |
R-HSA-70268 | Pyruvate metabolism | 5.592099e-01 | 0.252 |
R-HSA-9663891 | Selective autophagy | 5.629665e-01 | 0.250 |
R-HSA-9645723 | Diseases of programmed cell death | 5.629665e-01 | 0.250 |
R-HSA-376176 | Signaling by ROBO receptors | 5.647984e-01 | 0.248 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 5.776779e-01 | 0.238 |
R-HSA-6798695 | Neutrophil degranulation | 5.825409e-01 | 0.235 |
R-HSA-9837999 | Mitochondrial protein degradation | 5.883878e-01 | 0.230 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 5.911373e-01 | 0.228 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 5.918975e-01 | 0.228 |
R-HSA-72764 | Eukaryotic Translation Termination | 5.953775e-01 | 0.225 |
R-HSA-5683057 | MAPK family signaling cascades | 6.064326e-01 | 0.217 |
R-HSA-3214847 | HATs acetylate histones | 6.090054e-01 | 0.215 |
R-HSA-5610787 | Hedgehog 'off' state | 6.123405e-01 | 0.213 |
R-HSA-1483255 | PI Metabolism | 6.189264e-01 | 0.208 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 6.285974e-01 | 0.202 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 6.285974e-01 | 0.202 |
R-HSA-15869 | Metabolism of nucleotides | 6.423575e-01 | 0.192 |
R-HSA-2262752 | Cellular responses to stress | 6.644472e-01 | 0.178 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 6.649049e-01 | 0.177 |
R-HSA-9007101 | Rab regulation of trafficking | 6.734169e-01 | 0.172 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 6.844333e-01 | 0.165 |
R-HSA-2132295 | MHC class II antigen presentation | 6.898024e-01 | 0.161 |
R-HSA-6809371 | Formation of the cornified envelope | 6.924528e-01 | 0.160 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 6.976864e-01 | 0.156 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 6.976864e-01 | 0.156 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 6.976864e-01 | 0.156 |
R-HSA-114608 | Platelet degranulation | 7.028315e-01 | 0.153 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 7.053714e-01 | 0.152 |
R-HSA-9843745 | Adipogenesis | 7.153172e-01 | 0.146 |
R-HSA-5576891 | Cardiac conduction | 7.153172e-01 | 0.146 |
R-HSA-9909396 | Circadian clock | 7.177512e-01 | 0.144 |
R-HSA-1474228 | Degradation of the extracellular matrix | 7.177512e-01 | 0.144 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 7.201645e-01 | 0.143 |
R-HSA-9679506 | SARS-CoV Infections | 7.257703e-01 | 0.139 |
R-HSA-9658195 | Leishmania infection | 7.278671e-01 | 0.138 |
R-HSA-9824443 | Parasitic Infection Pathways | 7.278671e-01 | 0.138 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 7.295559e-01 | 0.137 |
R-HSA-5358351 | Signaling by Hedgehog | 7.342199e-01 | 0.134 |
R-HSA-6807070 | PTEN Regulation | 7.364934e-01 | 0.133 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 7.453957e-01 | 0.128 |
R-HSA-9018678 | Biosynthesis of specialized proresolving mediators (SPMs) | 7.475743e-01 | 0.126 |
R-HSA-166520 | Signaling by NTRKs | 7.581925e-01 | 0.120 |
R-HSA-9758941 | Gastrulation | 7.602623e-01 | 0.119 |
R-HSA-9856651 | MITF-M-dependent gene expression | 7.623145e-01 | 0.118 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 7.643493e-01 | 0.117 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 7.663668e-01 | 0.116 |
R-HSA-2142753 | Arachidonate metabolism | 7.663668e-01 | 0.116 |
R-HSA-9610379 | HCMV Late Events | 7.761999e-01 | 0.110 |
R-HSA-162587 | HIV Life Cycle | 7.761999e-01 | 0.110 |
R-HSA-9711097 | Cellular response to starvation | 7.781167e-01 | 0.109 |
R-HSA-2408522 | Selenoamino acid metabolism | 7.892798e-01 | 0.103 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 8.016004e-01 | 0.096 |
R-HSA-72306 | tRNA processing | 8.016004e-01 | 0.096 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 8.049873e-01 | 0.094 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 8.145795e-01 | 0.089 |
R-HSA-611105 | Respiratory electron transport | 8.148075e-01 | 0.089 |
R-HSA-2559583 | Cellular Senescence | 8.179706e-01 | 0.087 |
R-HSA-109582 | Hemostasis | 8.198158e-01 | 0.086 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 8.226148e-01 | 0.085 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 8.300953e-01 | 0.081 |
R-HSA-68877 | Mitotic Prometaphase | 8.372625e-01 | 0.077 |
R-HSA-389948 | Co-inhibition by PD-1 | 8.467951e-01 | 0.072 |
R-HSA-9640148 | Infection with Enterobacteria | 8.507088e-01 | 0.070 |
R-HSA-6805567 | Keratinization | 8.557731e-01 | 0.068 |
R-HSA-9748784 | Drug ADME | 8.699651e-01 | 0.060 |
R-HSA-8951664 | Neddylation | 8.732909e-01 | 0.059 |
R-HSA-162906 | HIV Infection | 8.796911e-01 | 0.056 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 8.807262e-01 | 0.055 |
R-HSA-72312 | rRNA processing | 8.847787e-01 | 0.053 |
R-HSA-1280218 | Adaptive Immune System | 8.969959e-01 | 0.047 |
R-HSA-72766 | Translation | 8.983196e-01 | 0.047 |
R-HSA-9609646 | HCMV Infection | 9.013881e-01 | 0.045 |
R-HSA-1643685 | Disease | 9.053818e-01 | 0.043 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 9.063780e-01 | 0.043 |
R-HSA-416476 | G alpha (q) signalling events | 9.126434e-01 | 0.040 |
R-HSA-9711123 | Cellular response to chemical stress | 9.156181e-01 | 0.038 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 9.198927e-01 | 0.036 |
R-HSA-1257604 | PIP3 activates AKT signaling | 9.332295e-01 | 0.030 |
R-HSA-1483257 | Phospholipid metabolism | 9.332295e-01 | 0.030 |
R-HSA-195721 | Signaling by WNT | 9.349454e-01 | 0.029 |
R-HSA-168249 | Innate Immune System | 9.468069e-01 | 0.024 |
R-HSA-9006925 | Intracellular signaling by second messengers | 9.556190e-01 | 0.020 |
R-HSA-9694516 | SARS-CoV-2 Infection | 9.582427e-01 | 0.019 |
R-HSA-9824446 | Viral Infection Pathways | 9.704265e-01 | 0.013 |
R-HSA-9824439 | Bacterial Infection Pathways | 9.710468e-01 | 0.013 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 9.720406e-01 | 0.012 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.740339e-01 | 0.011 |
R-HSA-8978868 | Fatty acid metabolism | 9.750424e-01 | 0.011 |
R-HSA-449147 | Signaling by Interleukins | 9.753589e-01 | 0.011 |
R-HSA-5663205 | Infectious disease | 9.819962e-01 | 0.008 |
R-HSA-168256 | Immune System | 9.858893e-01 | 0.006 |
R-HSA-500792 | GPCR ligand binding | 9.949611e-01 | 0.002 |
R-HSA-9709957 | Sensory Perception | 9.988500e-01 | 0.000 |
R-HSA-388396 | GPCR downstream signalling | 9.990282e-01 | 0.000 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 9.992901e-01 | 0.000 |
R-HSA-372790 | Signaling by GPCR | 9.995386e-01 | 0.000 |
R-HSA-556833 | Metabolism of lipids | 9.998395e-01 | 0.000 |
R-HSA-382551 | Transport of small molecules | 9.998495e-01 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000e+00 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
COT |
0.833 | 0.178 | 2 | 0.816 |
CDC7 |
0.829 | 0.191 | 1 | 0.854 |
MOS |
0.822 | 0.202 | 1 | 0.811 |
CLK3 |
0.816 | 0.110 | 1 | 0.727 |
BMPR1B |
0.816 | 0.276 | 1 | 0.833 |
DSTYK |
0.813 | 0.017 | 2 | 0.826 |
PRPK |
0.813 | -0.041 | -1 | 0.800 |
GRK6 |
0.813 | 0.174 | 1 | 0.809 |
RAF1 |
0.813 | -0.024 | 1 | 0.773 |
GRK1 |
0.813 | 0.146 | -2 | 0.702 |
PIM3 |
0.813 | 0.028 | -3 | 0.713 |
CAMK2G |
0.813 | 0.040 | 2 | 0.798 |
RSK2 |
0.813 | 0.059 | -3 | 0.664 |
GCN2 |
0.812 | -0.069 | 2 | 0.760 |
IKKB |
0.811 | -0.052 | -2 | 0.666 |
TBK1 |
0.811 | -0.054 | 1 | 0.665 |
MTOR |
0.810 | -0.069 | 1 | 0.676 |
CAMK1B |
0.809 | -0.010 | -3 | 0.763 |
NDR2 |
0.809 | -0.012 | -3 | 0.712 |
ATR |
0.809 | 0.030 | 1 | 0.769 |
BMPR2 |
0.808 | -0.027 | -2 | 0.799 |
FAM20C |
0.807 | 0.133 | 2 | 0.615 |
IKKE |
0.806 | -0.080 | 1 | 0.663 |
ULK2 |
0.806 | -0.123 | 2 | 0.747 |
MST4 |
0.805 | 0.042 | 2 | 0.800 |
NLK |
0.805 | -0.032 | 1 | 0.706 |
TGFBR2 |
0.805 | -0.001 | -2 | 0.723 |
CDKL1 |
0.805 | -0.004 | -3 | 0.698 |
IKKA |
0.805 | 0.028 | -2 | 0.653 |
GRK5 |
0.805 | -0.000 | -3 | 0.765 |
PRKD1 |
0.804 | -0.011 | -3 | 0.687 |
PDHK4 |
0.804 | -0.246 | 1 | 0.752 |
PIM1 |
0.804 | 0.044 | -3 | 0.670 |
PRKD2 |
0.804 | 0.020 | -3 | 0.648 |
PKN3 |
0.804 | -0.011 | -3 | 0.700 |
BMPR1A |
0.803 | 0.257 | 1 | 0.833 |
TGFBR1 |
0.802 | 0.131 | -2 | 0.710 |
P90RSK |
0.802 | -0.002 | -3 | 0.655 |
SKMLCK |
0.802 | -0.002 | -2 | 0.760 |
RIPK3 |
0.802 | -0.064 | 3 | 0.697 |
PKCD |
0.801 | 0.039 | 2 | 0.759 |
RSK3 |
0.801 | 0.001 | -3 | 0.667 |
ATM |
0.801 | 0.075 | 1 | 0.752 |
KIS |
0.801 | 0.013 | 1 | 0.572 |
NEK6 |
0.801 | -0.064 | -2 | 0.779 |
NDR1 |
0.801 | -0.035 | -3 | 0.709 |
ACVR2B |
0.801 | 0.184 | -2 | 0.727 |
P70S6KB |
0.801 | 0.017 | -3 | 0.687 |
MLK1 |
0.801 | -0.031 | 2 | 0.768 |
NIK |
0.801 | -0.052 | -3 | 0.772 |
WNK1 |
0.801 | -0.049 | -2 | 0.790 |
PDHK1 |
0.800 | -0.205 | 1 | 0.745 |
DAPK2 |
0.800 | -0.011 | -3 | 0.751 |
ERK5 |
0.800 | -0.051 | 1 | 0.648 |
CAMLCK |
0.799 | -0.036 | -2 | 0.765 |
AMPKA1 |
0.799 | -0.011 | -3 | 0.725 |
GRK4 |
0.799 | -0.009 | -2 | 0.732 |
PKN2 |
0.799 | -0.010 | -3 | 0.717 |
PLK1 |
0.799 | 0.068 | -2 | 0.748 |
MARK4 |
0.798 | -0.050 | 4 | 0.785 |
MAPKAPK2 |
0.798 | 0.021 | -3 | 0.613 |
CAMK2B |
0.798 | 0.060 | 2 | 0.770 |
ACVR2A |
0.798 | 0.156 | -2 | 0.713 |
GRK7 |
0.798 | 0.144 | 1 | 0.715 |
ALK4 |
0.798 | 0.082 | -2 | 0.736 |
NUAK2 |
0.798 | -0.037 | -3 | 0.720 |
NEK7 |
0.797 | -0.156 | -3 | 0.724 |
TSSK2 |
0.797 | 0.015 | -5 | 0.801 |
RSK4 |
0.797 | 0.056 | -3 | 0.627 |
CDKL5 |
0.797 | -0.024 | -3 | 0.680 |
SRPK1 |
0.797 | -0.000 | -3 | 0.646 |
ALK2 |
0.797 | 0.163 | -2 | 0.723 |
ULK1 |
0.797 | -0.146 | -3 | 0.705 |
LATS2 |
0.797 | -0.037 | -5 | 0.734 |
PKACG |
0.797 | -0.004 | -2 | 0.695 |
WNK3 |
0.796 | -0.157 | 1 | 0.704 |
BCKDK |
0.796 | -0.125 | -1 | 0.787 |
CAMK2D |
0.796 | -0.057 | -3 | 0.711 |
HUNK |
0.795 | -0.110 | 2 | 0.740 |
PLK3 |
0.795 | 0.116 | 2 | 0.731 |
MAPKAPK3 |
0.795 | -0.048 | -3 | 0.645 |
CHAK2 |
0.795 | -0.085 | -1 | 0.783 |
NIM1 |
0.794 | -0.050 | 3 | 0.721 |
TSSK1 |
0.793 | -0.009 | -3 | 0.738 |
SRPK2 |
0.793 | 0.005 | -3 | 0.580 |
CAMK2A |
0.793 | 0.036 | 2 | 0.775 |
ICK |
0.792 | -0.040 | -3 | 0.717 |
ANKRD3 |
0.792 | -0.100 | 1 | 0.762 |
AMPKA2 |
0.792 | -0.023 | -3 | 0.695 |
HIPK4 |
0.792 | -0.064 | 1 | 0.647 |
MLK3 |
0.792 | 0.030 | 2 | 0.710 |
DLK |
0.792 | -0.110 | 1 | 0.757 |
AURC |
0.791 | 0.004 | -2 | 0.598 |
PAK1 |
0.791 | -0.032 | -2 | 0.697 |
PRKX |
0.791 | 0.073 | -3 | 0.564 |
DNAPK |
0.790 | 0.063 | 1 | 0.683 |
CK2A2 |
0.790 | 0.238 | 1 | 0.721 |
PRKD3 |
0.790 | -0.020 | -3 | 0.652 |
TTBK2 |
0.789 | -0.121 | 2 | 0.642 |
IRE2 |
0.789 | -0.024 | 2 | 0.751 |
PKACB |
0.789 | 0.023 | -2 | 0.623 |
MLK4 |
0.789 | 0.020 | 2 | 0.681 |
LATS1 |
0.788 | 0.006 | -3 | 0.714 |
CDK8 |
0.788 | -0.040 | 1 | 0.550 |
MSK2 |
0.788 | -0.054 | -3 | 0.633 |
MASTL |
0.788 | -0.266 | -2 | 0.731 |
PKCB |
0.788 | 0.011 | 2 | 0.703 |
PKR |
0.788 | -0.014 | 1 | 0.721 |
PKCG |
0.788 | 0.004 | 2 | 0.704 |
PKCA |
0.787 | 0.003 | 2 | 0.702 |
CAMK4 |
0.787 | -0.094 | -3 | 0.707 |
NEK9 |
0.787 | -0.206 | 2 | 0.782 |
MLK2 |
0.787 | -0.141 | 2 | 0.767 |
JNK2 |
0.787 | 0.025 | 1 | 0.518 |
MSK1 |
0.786 | -0.015 | -3 | 0.633 |
RIPK1 |
0.786 | -0.204 | 1 | 0.710 |
SIK |
0.786 | -0.046 | -3 | 0.657 |
PAK3 |
0.786 | -0.083 | -2 | 0.698 |
QSK |
0.786 | -0.050 | 4 | 0.761 |
MELK |
0.786 | -0.066 | -3 | 0.679 |
IRE1 |
0.785 | -0.099 | 1 | 0.657 |
AURB |
0.785 | -0.016 | -2 | 0.591 |
GRK2 |
0.785 | 0.033 | -2 | 0.618 |
SRPK3 |
0.785 | -0.020 | -3 | 0.636 |
MNK2 |
0.785 | -0.044 | -2 | 0.717 |
NUAK1 |
0.785 | -0.073 | -3 | 0.683 |
SGK3 |
0.785 | 0.011 | -3 | 0.638 |
QIK |
0.784 | -0.104 | -3 | 0.713 |
BRAF |
0.784 | 0.031 | -4 | 0.769 |
BRSK1 |
0.784 | -0.046 | -3 | 0.678 |
MEK1 |
0.784 | -0.128 | 2 | 0.777 |
PKG2 |
0.784 | 0.001 | -2 | 0.642 |
PKCH |
0.784 | -0.021 | 2 | 0.699 |
SMG1 |
0.783 | -0.021 | 1 | 0.721 |
CDK1 |
0.783 | -0.000 | 1 | 0.530 |
MARK2 |
0.783 | -0.040 | 4 | 0.688 |
PAK6 |
0.783 | -0.030 | -2 | 0.622 |
AKT2 |
0.783 | 0.007 | -3 | 0.593 |
MYLK4 |
0.783 | -0.039 | -2 | 0.684 |
JNK3 |
0.783 | 0.007 | 1 | 0.541 |
YSK4 |
0.783 | -0.101 | 1 | 0.689 |
DRAK1 |
0.783 | 0.008 | 1 | 0.762 |
MARK3 |
0.783 | -0.036 | 4 | 0.721 |
DYRK2 |
0.782 | -0.040 | 1 | 0.570 |
AURA |
0.781 | -0.017 | -2 | 0.544 |
CDK5 |
0.781 | -0.003 | 1 | 0.570 |
CDK19 |
0.781 | -0.045 | 1 | 0.516 |
CLK4 |
0.781 | -0.035 | -3 | 0.661 |
PIM2 |
0.781 | 0.002 | -3 | 0.642 |
CLK2 |
0.781 | 0.035 | -3 | 0.645 |
PLK2 |
0.781 | 0.217 | -3 | 0.883 |
P38A |
0.781 | -0.009 | 1 | 0.561 |
CDK7 |
0.780 | -0.065 | 1 | 0.558 |
PLK4 |
0.780 | -0.072 | 2 | 0.620 |
PAK2 |
0.780 | -0.089 | -2 | 0.680 |
VRK2 |
0.779 | -0.228 | 1 | 0.753 |
CLK1 |
0.779 | -0.028 | -3 | 0.652 |
TLK2 |
0.779 | -0.071 | 1 | 0.702 |
MNK1 |
0.779 | -0.040 | -2 | 0.731 |
CK2A1 |
0.778 | 0.201 | 1 | 0.702 |
MARK1 |
0.778 | -0.060 | 4 | 0.746 |
CDK18 |
0.778 | -0.017 | 1 | 0.486 |
NEK2 |
0.778 | -0.150 | 2 | 0.754 |
BRSK2 |
0.777 | -0.115 | -3 | 0.692 |
P38B |
0.777 | -0.006 | 1 | 0.507 |
CHK1 |
0.777 | -0.068 | -3 | 0.710 |
ERK1 |
0.777 | -0.014 | 1 | 0.498 |
PHKG1 |
0.777 | -0.113 | -3 | 0.698 |
CHAK1 |
0.777 | -0.138 | 2 | 0.710 |
P38G |
0.776 | -0.004 | 1 | 0.443 |
PERK |
0.776 | -0.105 | -2 | 0.768 |
PKCZ |
0.776 | -0.095 | 2 | 0.731 |
MEKK3 |
0.776 | -0.074 | 1 | 0.713 |
ERK2 |
0.775 | -0.031 | 1 | 0.534 |
CK1E |
0.774 | -0.032 | -3 | 0.496 |
SMMLCK |
0.774 | -0.037 | -3 | 0.714 |
GRK3 |
0.774 | 0.030 | -2 | 0.572 |
SSTK |
0.774 | -0.011 | 4 | 0.766 |
ZAK |
0.774 | -0.076 | 1 | 0.709 |
CDK17 |
0.774 | -0.025 | 1 | 0.448 |
CDK2 |
0.774 | -0.054 | 1 | 0.605 |
DCAMKL1 |
0.773 | -0.055 | -3 | 0.667 |
HIPK1 |
0.773 | -0.024 | 1 | 0.580 |
HIPK2 |
0.773 | -0.018 | 1 | 0.486 |
MST3 |
0.773 | 0.003 | 2 | 0.772 |
AKT1 |
0.773 | -0.003 | -3 | 0.595 |
PKACA |
0.773 | -0.003 | -2 | 0.584 |
CDK13 |
0.772 | -0.076 | 1 | 0.531 |
CAMK1G |
0.772 | -0.083 | -3 | 0.659 |
MEKK1 |
0.772 | -0.136 | 1 | 0.716 |
MEKK2 |
0.771 | -0.057 | 2 | 0.757 |
TAO3 |
0.771 | -0.029 | 1 | 0.699 |
WNK4 |
0.771 | -0.125 | -2 | 0.784 |
CDK16 |
0.771 | 0.021 | 1 | 0.459 |
IRAK4 |
0.771 | -0.104 | 1 | 0.677 |
HRI |
0.771 | -0.174 | -2 | 0.770 |
P70S6K |
0.771 | -0.037 | -3 | 0.605 |
SNRK |
0.771 | -0.195 | 2 | 0.670 |
DAPK3 |
0.771 | 0.017 | -3 | 0.686 |
PKCT |
0.771 | -0.042 | 2 | 0.707 |
P38D |
0.770 | 0.001 | 1 | 0.463 |
DYRK1A |
0.770 | -0.049 | 1 | 0.604 |
MEK5 |
0.769 | -0.218 | 2 | 0.770 |
CDK3 |
0.769 | -0.010 | 1 | 0.466 |
PASK |
0.769 | -0.019 | -3 | 0.728 |
PHKG2 |
0.769 | -0.083 | -3 | 0.697 |
CAMK1D |
0.768 | -0.034 | -3 | 0.592 |
DCAMKL2 |
0.768 | -0.074 | -3 | 0.701 |
NEK5 |
0.768 | -0.162 | 1 | 0.710 |
PRP4 |
0.768 | -0.086 | -3 | 0.602 |
TLK1 |
0.767 | -0.119 | -2 | 0.734 |
CDK14 |
0.766 | -0.032 | 1 | 0.531 |
DYRK4 |
0.766 | -0.034 | 1 | 0.508 |
PINK1 |
0.766 | -0.197 | 1 | 0.669 |
DYRK1B |
0.765 | -0.041 | 1 | 0.526 |
CDK12 |
0.765 | -0.078 | 1 | 0.508 |
DAPK1 |
0.765 | 0.004 | -3 | 0.674 |
MAPKAPK5 |
0.765 | -0.176 | -3 | 0.593 |
HIPK3 |
0.765 | -0.067 | 1 | 0.570 |
PKCE |
0.765 | 0.006 | 2 | 0.693 |
CAMKK1 |
0.764 | -0.137 | -2 | 0.703 |
GAK |
0.764 | -0.021 | 1 | 0.715 |
NEK11 |
0.764 | -0.125 | 1 | 0.717 |
SGK1 |
0.764 | 0.014 | -3 | 0.515 |
TTBK1 |
0.764 | -0.147 | 2 | 0.568 |
TAO2 |
0.764 | -0.072 | 2 | 0.810 |
CDK10 |
0.763 | -0.015 | 1 | 0.520 |
CK1D |
0.763 | -0.049 | -3 | 0.442 |
MST2 |
0.763 | -0.025 | 1 | 0.731 |
CK1A2 |
0.762 | -0.048 | -3 | 0.447 |
JNK1 |
0.762 | -0.009 | 1 | 0.505 |
MPSK1 |
0.762 | -0.077 | 1 | 0.622 |
AKT3 |
0.762 | -0.001 | -3 | 0.526 |
IRAK1 |
0.761 | -0.211 | -1 | 0.727 |
CK1G1 |
0.761 | -0.093 | -3 | 0.499 |
DYRK3 |
0.760 | -0.059 | 1 | 0.583 |
CDK9 |
0.760 | -0.113 | 1 | 0.538 |
NEK8 |
0.760 | -0.156 | 2 | 0.775 |
PKCI |
0.760 | -0.081 | 2 | 0.699 |
PAK5 |
0.760 | -0.085 | -2 | 0.554 |
CAMKK2 |
0.760 | -0.145 | -2 | 0.702 |
GCK |
0.760 | -0.037 | 1 | 0.721 |
TAK1 |
0.760 | -0.049 | 1 | 0.746 |
EEF2K |
0.759 | -0.016 | 3 | 0.757 |
GSK3A |
0.759 | -0.032 | 4 | 0.372 |
MINK |
0.759 | -0.040 | 1 | 0.701 |
MRCKB |
0.759 | -0.007 | -3 | 0.635 |
GSK3B |
0.759 | -0.066 | 4 | 0.361 |
MAP3K15 |
0.758 | -0.076 | 1 | 0.678 |
ROCK2 |
0.758 | 0.010 | -3 | 0.660 |
TNIK |
0.758 | -0.016 | 3 | 0.766 |
PDK1 |
0.757 | -0.135 | 1 | 0.702 |
MRCKA |
0.757 | -0.019 | -3 | 0.644 |
PAK4 |
0.757 | -0.081 | -2 | 0.553 |
HGK |
0.757 | -0.066 | 3 | 0.765 |
PKN1 |
0.756 | -0.063 | -3 | 0.615 |
MEKK6 |
0.756 | -0.105 | 1 | 0.677 |
CAMK1A |
0.755 | -0.048 | -3 | 0.574 |
NEK4 |
0.755 | -0.165 | 1 | 0.686 |
HPK1 |
0.754 | -0.054 | 1 | 0.714 |
MAK |
0.753 | 0.005 | -2 | 0.686 |
LKB1 |
0.753 | -0.174 | -3 | 0.684 |
BUB1 |
0.753 | 0.012 | -5 | 0.789 |
CHK2 |
0.753 | -0.064 | -3 | 0.546 |
LOK |
0.753 | -0.091 | -2 | 0.720 |
ERK7 |
0.753 | -0.052 | 2 | 0.478 |
TTK |
0.752 | 0.069 | -2 | 0.748 |
KHS2 |
0.751 | -0.005 | 1 | 0.708 |
KHS1 |
0.751 | -0.035 | 1 | 0.691 |
DMPK1 |
0.751 | 0.021 | -3 | 0.662 |
CDK6 |
0.751 | -0.048 | 1 | 0.507 |
VRK1 |
0.751 | -0.163 | 2 | 0.801 |
MST1 |
0.750 | -0.086 | 1 | 0.700 |
SBK |
0.750 | -0.029 | -3 | 0.490 |
LRRK2 |
0.750 | -0.191 | 2 | 0.795 |
CDK4 |
0.749 | -0.054 | 1 | 0.493 |
MEK2 |
0.747 | -0.212 | 2 | 0.760 |
NEK1 |
0.747 | -0.182 | 1 | 0.685 |
PKG1 |
0.747 | -0.042 | -2 | 0.590 |
MOK |
0.747 | -0.024 | 1 | 0.571 |
SLK |
0.747 | -0.118 | -2 | 0.655 |
PDHK3_TYR |
0.746 | 0.117 | 4 | 0.847 |
YSK1 |
0.746 | -0.096 | 2 | 0.755 |
ALPHAK3 |
0.745 | 0.066 | -1 | 0.711 |
RIPK2 |
0.744 | -0.244 | 1 | 0.675 |
PBK |
0.744 | -0.076 | 1 | 0.617 |
ROCK1 |
0.744 | -0.013 | -3 | 0.638 |
STK33 |
0.743 | -0.191 | 2 | 0.565 |
CRIK |
0.742 | -0.001 | -3 | 0.590 |
EPHA6 |
0.741 | 0.163 | -1 | 0.838 |
OSR1 |
0.740 | -0.067 | 2 | 0.727 |
HASPIN |
0.739 | -0.020 | -1 | 0.673 |
BMPR2_TYR |
0.738 | 0.082 | -1 | 0.831 |
TXK |
0.738 | 0.216 | 1 | 0.802 |
ASK1 |
0.737 | -0.092 | 1 | 0.674 |
PDHK4_TYR |
0.736 | 0.016 | 2 | 0.830 |
MAP2K6_TYR |
0.736 | 0.009 | -1 | 0.811 |
EPHB4 |
0.736 | 0.099 | -1 | 0.818 |
MAP2K4_TYR |
0.735 | -0.069 | -1 | 0.813 |
NEK3 |
0.735 | -0.217 | 1 | 0.645 |
BIKE |
0.735 | -0.041 | 1 | 0.590 |
TESK1_TYR |
0.735 | -0.083 | 3 | 0.810 |
PDHK1_TYR |
0.734 | 0.007 | -1 | 0.826 |
MAP2K7_TYR |
0.734 | -0.153 | 2 | 0.817 |
MYO3A |
0.733 | -0.059 | 1 | 0.679 |
PKMYT1_TYR |
0.733 | -0.092 | 3 | 0.785 |
MYO3B |
0.731 | -0.098 | 2 | 0.777 |
PINK1_TYR |
0.731 | -0.121 | 1 | 0.724 |
SRMS |
0.731 | 0.136 | 1 | 0.814 |
YES1 |
0.730 | 0.075 | -1 | 0.814 |
EPHB2 |
0.729 | 0.122 | -1 | 0.808 |
YANK3 |
0.729 | -0.095 | 2 | 0.357 |
TAO1 |
0.729 | -0.128 | 1 | 0.630 |
EPHA4 |
0.729 | 0.078 | 2 | 0.727 |
RET |
0.729 | -0.065 | 1 | 0.693 |
FER |
0.728 | 0.049 | 1 | 0.808 |
EPHB1 |
0.728 | 0.073 | 1 | 0.808 |
CK1A |
0.728 | -0.072 | -3 | 0.368 |
LIMK2_TYR |
0.727 | -0.091 | -3 | 0.761 |
TYRO3 |
0.727 | -0.037 | 3 | 0.717 |
LCK |
0.727 | 0.120 | -1 | 0.819 |
BLK |
0.726 | 0.134 | -1 | 0.819 |
INSRR |
0.725 | 0.024 | 3 | 0.691 |
ABL2 |
0.725 | 0.020 | -1 | 0.776 |
CSF1R |
0.725 | -0.022 | 3 | 0.726 |
ROS1 |
0.725 | -0.062 | 3 | 0.692 |
FYN |
0.724 | 0.149 | -1 | 0.802 |
ITK |
0.724 | 0.056 | -1 | 0.784 |
EPHB3 |
0.724 | 0.044 | -1 | 0.811 |
DDR1 |
0.724 | -0.117 | 4 | 0.785 |
HCK |
0.724 | 0.045 | -1 | 0.811 |
TYK2 |
0.723 | -0.150 | 1 | 0.694 |
MST1R |
0.723 | -0.124 | 3 | 0.740 |
TEC |
0.723 | 0.081 | -1 | 0.736 |
EPHA7 |
0.722 | 0.074 | 2 | 0.726 |
MERTK |
0.722 | 0.031 | 3 | 0.719 |
LIMK1_TYR |
0.722 | -0.195 | 2 | 0.813 |
JAK2 |
0.721 | -0.133 | 1 | 0.694 |
JAK3 |
0.721 | -0.062 | 1 | 0.684 |
ABL1 |
0.721 | -0.002 | -1 | 0.774 |
STLK3 |
0.720 | -0.179 | 1 | 0.673 |
FLT3 |
0.719 | -0.039 | 3 | 0.715 |
BMX |
0.719 | 0.032 | -1 | 0.711 |
TNK2 |
0.718 | -0.069 | 3 | 0.717 |
AXL |
0.718 | -0.037 | 3 | 0.721 |
KIT |
0.718 | -0.053 | 3 | 0.734 |
FGR |
0.717 | -0.092 | 1 | 0.733 |
FGFR2 |
0.717 | -0.079 | 3 | 0.746 |
PDGFRB |
0.717 | -0.097 | 3 | 0.733 |
FRK |
0.716 | 0.054 | -1 | 0.816 |
EPHA5 |
0.715 | 0.076 | 2 | 0.720 |
KDR |
0.715 | -0.061 | 3 | 0.696 |
AAK1 |
0.715 | -0.026 | 1 | 0.486 |
TEK |
0.715 | -0.078 | 3 | 0.674 |
PTK2B |
0.715 | 0.061 | -1 | 0.777 |
ALK |
0.715 | -0.031 | 3 | 0.661 |
PTK6 |
0.715 | -0.052 | -1 | 0.711 |
EPHA3 |
0.714 | -0.034 | 2 | 0.710 |
BTK |
0.714 | -0.049 | -1 | 0.748 |
LTK |
0.714 | -0.036 | 3 | 0.682 |
EPHA1 |
0.713 | -0.012 | 3 | 0.697 |
LYN |
0.713 | 0.051 | 3 | 0.661 |
EPHA8 |
0.712 | 0.056 | -1 | 0.799 |
FGFR1 |
0.712 | -0.112 | 3 | 0.712 |
MET |
0.712 | -0.045 | 3 | 0.720 |
JAK1 |
0.712 | -0.082 | 1 | 0.653 |
PTK2 |
0.710 | 0.101 | -1 | 0.778 |
NEK10_TYR |
0.709 | -0.152 | 1 | 0.573 |
SYK |
0.709 | 0.115 | -1 | 0.742 |
TNK1 |
0.709 | -0.148 | 3 | 0.697 |
CK1G3 |
0.709 | -0.083 | -3 | 0.327 |
NTRK1 |
0.709 | -0.109 | -1 | 0.772 |
SRC |
0.709 | 0.043 | -1 | 0.796 |
FLT1 |
0.708 | -0.061 | -1 | 0.788 |
PDGFRA |
0.708 | -0.172 | 3 | 0.731 |
ERBB2 |
0.708 | -0.090 | 1 | 0.677 |
FGFR3 |
0.708 | -0.078 | 3 | 0.720 |
WEE1_TYR |
0.706 | -0.102 | -1 | 0.714 |
NTRK2 |
0.706 | -0.119 | 3 | 0.711 |
EGFR |
0.706 | -0.014 | 1 | 0.603 |
TNNI3K_TYR |
0.706 | -0.132 | 1 | 0.694 |
INSR |
0.705 | -0.096 | 3 | 0.661 |
FLT4 |
0.703 | -0.132 | 3 | 0.700 |
CSK |
0.703 | -0.030 | 2 | 0.732 |
DDR2 |
0.702 | -0.086 | 3 | 0.693 |
EPHA2 |
0.701 | 0.021 | -1 | 0.760 |
MATK |
0.701 | -0.073 | -1 | 0.698 |
NTRK3 |
0.700 | -0.109 | -1 | 0.725 |
FGFR4 |
0.699 | -0.047 | -1 | 0.731 |
YANK2 |
0.697 | -0.113 | 2 | 0.373 |
ERBB4 |
0.697 | -0.001 | 1 | 0.655 |
IGF1R |
0.693 | -0.082 | 3 | 0.610 |
FES |
0.688 | -0.027 | -1 | 0.694 |
CK1G2 |
0.686 | -0.092 | -3 | 0.419 |
MUSK |
0.685 | -0.144 | 1 | 0.566 |
ZAP70 |
0.672 | -0.050 | -1 | 0.670 |